BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J 2020;41:3038-44. [PMID: 32882706 DOI: 10.1093/eurheartj/ehaa623] [Cited by in Crossref: 212] [Cited by in F6Publishing: 206] [Article Influence: 106.0] [Reference Citation Analysis]
Number Citing Articles
1 Almeida LV, Garcia-Araujo A, Lopez M, Rocha DS, Mendes RG, Borghi-Silva A, Dibai-Filho AV, Dibai DB. Results and effects of patients who have recovered from COVID-19: identifying the relationship with risk factors and comorbidities. Cien Saude Colet 2022;27:2963-72. [PMID: 35894310 DOI: 10.1590/1413-81232022278.18672021] [Reference Citation Analysis]
2 Álvarez Moreno Y, Bú Figueroa J, Bú Figueroa E, Soto Fonseca M, Escober Torres J. Internal carotid artery thrombosis in COVID 19. Colomb Med (Cali) 2020;51:e504560. [PMID: 33402757 DOI: 10.25100/cm.v51i3.4560] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, Luo S, Li Z, Liu P, Han J, Harding IC, Ebong EE, Cameron SJ, Stewart AG, Weng J. Endothelial Dysfunction in Atherosclerotic Cardiovascular Diseases and Beyond: From Mechanism to Pharmacotherapies. Pharmacol Rev 2021;73:924-67. [PMID: 34088867 DOI: 10.1124/pharmrev.120.000096] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
4 Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, Signorovitch J, Thune JJ, Vardeny O, Solomon SD. Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19. JACC Heart Fail 2021;9:65-73. [PMID: 33384064 DOI: 10.1016/j.jchf.2020.11.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 18.0] [Reference Citation Analysis]
5 Lima JAC, Bluemke DA. Cardiac Abnormalities Depicted with MRI in COVID-19: Ongoing Concern for Myocardial Injury. Radiology 2021;:211492. [PMID: 34309439 DOI: 10.1148/radiol.2021211492] [Reference Citation Analysis]
6 Agostinis C, Mangogna A, Balduit A, Aghamajidi A, Ricci G, Kishore U, Bulla R. COVID-19, Pre-Eclampsia, and Complement System. Front Immunol 2021;12:775168. [PMID: 34868042 DOI: 10.3389/fimmu.2021.775168] [Reference Citation Analysis]
7 Strauss SA, Seo C, Carrier M, Jetty P. From cellular function to global impact: the vascular perspective on COVID-19. Can J Surg 2021;64:E289-97. [PMID: 33978563 DOI: 10.1503/cjs.023820] [Reference Citation Analysis]
8 Catar R, Moll G, Kamhieh-Milz J, Luecht C, Chen L, Zhao H, Ernst L, Willy K, Girndt M, Fiedler R, Witowski J, Morawietz H, Ringdén O, Dragun D, Eckardt KU, Schindler R, Zickler D. Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling. Front Immunol 2021;12:774052. [PMID: 34858433 DOI: 10.3389/fimmu.2021.774052] [Reference Citation Analysis]
9 Mei ZW, van Wijk XMR, Pham HP, Marin MJ. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J Appl Lab Med 2021:jfab042. [PMID: 33930144 DOI: 10.1093/jalm/jfab042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Scheim DE. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Int J Mol Sci 2022;23:2558. [PMID: 35269703 DOI: 10.3390/ijms23052558] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
11 Zdanyte M, Rath D, Gawaz M, Geisler T. Venous Thrombosis and SARS-CoV-2. Hamostaseologie 2021. [PMID: 34879422 DOI: 10.1055/a-1661-0283] [Reference Citation Analysis]
12 Trinity JD, Craig JC, Fermoyle CC, McKenzie AI, Lewis MT, Park SH, Rondina MT, Richardson RS. Impact of presymptomatic COVID-19 on vascular and skeletal muscle function: a case study. J Appl Physiol (1985) 2021;130:1961-70. [PMID: 34002634 DOI: 10.1152/japplphysiol.00236.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Simon TP, Stoppe C, Breuer T, Stiehler L, Dreher M, Kersten A, Kluge S, Karakas M, Zechendorf E, Marx G, Martin L. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study. J Clin Med 2021;10:1667. [PMID: 33924637 DOI: 10.3390/jcm10081667] [Reference Citation Analysis]
14 Ergül E, Yılmaz AS, Öğütveren MM, Emlek N, Kostakoğlu U, Çetin M. COVID 19 disease independently predicted endothelial dysfunction measured by flow-mediated dilatation. Int J Cardiovasc Imaging 2021. [PMID: 34286447 DOI: 10.1007/s10554-021-02356-3] [Reference Citation Analysis]
15 Zhang J, Tecson KM, McCullough PA. Role of endothelial cell receptors in the context of SARS-CoV-2 infection (COVID-19). Proc (Bayl Univ Med Cent) 2021;34:262-8. [PMID: 33664552 DOI: 10.1080/08998280.2021.1874231] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Xu S, Liu Y, Ding Y, Luo S, Zheng X, Wu X, Liu Z, Ilyas I, Chen S, Han S, Little PJ, Jain MK, Weng J. The zinc finger transcription factor, KLF2, protects against COVID-19 associated endothelial dysfunction. Signal Transduct Target Ther 2021;6:266. [PMID: 34253708 DOI: 10.1038/s41392-021-00690-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Canale MP, Menghini R, Martelli E, Federici M. COVID-19–Associated Endothelial Dysfunction and Microvascular Injury. Cardiac Electrophysiology Clinics 2021. [DOI: 10.1016/j.ccep.2021.10.003] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Al Mahmeed W, Al-Rasadi K, Banerjee Y, Ceriello A, Cosentino F, Galia M, Goh SY, Kempler P, Lessan N, Papanas N, Rizvi AA, Santos RD, Stoian AP, Toth PP, Rizzo M; CArdiometabolic Panel of International experts on Syndemic COvid-19 (CAPISCO). Promoting a Syndemic Approach for Cardiometabolic Disease Management During COVID-19: The CAPISCO International Expert Panel. Front Cardiovasc Med 2021;8:787761. [PMID: 34977193 DOI: 10.3389/fcvm.2021.787761] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
19 Bussmann BM, Shabbir A, Warwick A, Orr W. Acute coronary artery thrombosis presenting as asymptomatic ST-elevation myocardial infarction in a patient with COVID-19 pneumonia. BMJ Case Rep 2021;14:e241856. [PMID: 33619149 DOI: 10.1136/bcr-2021-241856] [Reference Citation Analysis]
20 Lozahic C, Maddock H, Sandhu H. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19. Front Cardiovasc Med 2021;8:634291. [PMID: 33969006 DOI: 10.3389/fcvm.2021.634291] [Reference Citation Analysis]
21 Corica B, Marra AM, Basili S, Cangemi R, Cittadini A, Proietti M, Romiti GF. Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19: a systematic review and meta-analysis. Sci Rep 2021;11:17774. [PMID: 34493763 DOI: 10.1038/s41598-021-96955-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 West NEJ, Cheong WF, Boone E, Moat NE. Impact of the COVID-19 pandemic: a perspective from industry. Eur Heart J Suppl 2020;22:P56-9. [PMID: 33390873 DOI: 10.1093/eurheartj/suaa187] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 García-Pérez BE, González-Rojas JA, Salazar MI, Torres-Torres C, Castrejón-Jiménez NS. Taming the Autophagy as a Strategy for Treating COVID-19. Cells 2020;9:E2679. [PMID: 33322168 DOI: 10.3390/cells9122679] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
24 DeBoer RE, Oladunjoye OO, Herb R. Right Ovarian Vein Thrombosis in the Setting of COVID-19 Infection. Cureus 2021;13:e12796. [PMID: 33628665 DOI: 10.7759/cureus.12796] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Aktaa S, Wu J, Nadarajah R, Rashid M, de Belder M, Deanfield J, Mamas MA, Gale CP. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study. Thromb Res 2021;202:17-23. [PMID: 33711754 DOI: 10.1016/j.thromres.2021.03.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
26 Rey JR, Merino Llorens JL, Iniesta Manjavacas ÁM, Rodríguez SOR, Castrejón-Castrejón S, Arbas-Redondo E, Poveda-Pinedo ID, Tebar-Márquez D, Severo-Sánchez A, Rivero-Santana B, Juárez-Olmos V, Martínez-Cossiani M, Buño-Soto A, Gonzalez-Valle L, Herrero-Ambrosio A, López-de-Sá E, Caro-Codón J. Influence of statin treatment in a cohort of patients admitted for COVID-19. Med Clin (Barc) 2021:S0025-7753(21)00431-0. [PMID: 34511251 DOI: 10.1016/j.medcli.2021.07.003] [Reference Citation Analysis]
27 Wolfe J, Safdar B, Madsen TE, Sethuraman KN, Becker B, Greenberg MR, McGregor AJ. Sex- or Gender-specific Differences in the Clinical Presentation, Outcome, and Treatment of SARS-CoV-2. Clin Ther 2021;43:557-571.e1. [PMID: 33583576 DOI: 10.1016/j.clinthera.2021.01.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
28 Gheblawi M, de Oliveira AA, Williams VR, John R, Grant MB, Scholey JW, Oudit GY. An advanced endothelial murine HFpEF model: eNOS is critical for angiotensin 1-7 rescue of the diabetic phenotype. J Mol Cell Cardiol 2022:S0022-2828(22)00080-3. [PMID: 35489389 DOI: 10.1016/j.yjmcc.2022.04.015] [Reference Citation Analysis]
29 Colombo C, Garatti L, Ferrante G, Casadei F, Montalto C, Crimi G, Cogliati C, Ammirati E, Savonitto S, Morici N. Cardiovascular injuries and SARS-COV-2 infection: focus on elderly people. J Geriatr Cardiol 2021;18:534-48. [PMID: 34404990 DOI: 10.11909/j.issn.1671-5411.2021.07.001] [Reference Citation Analysis]
30 Schultheiss HP, Baumeier C, Pietsch H, Bock CT, Poller W, Escher F. Cardiovascular consequences of viral infections: from COVID to other viral diseases. Cardiovasc Res 2021:cvab315. [PMID: 34609508 DOI: 10.1093/cvr/cvab315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Muhanna D, Arnipalli SR, Kumar SB, Ziouzenkova O. Osmotic Adaptation by Na+-Dependent Transporters and ACE2: Correlation with Hemostatic Crisis in COVID-19. Biomedicines 2020;8:E460. [PMID: 33142989 DOI: 10.3390/biomedicines8110460] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Keane G, Dorman T. Fatal pulmonary thromboembolism in asymptomatic COVID-19. Ir J Med Sci 2021. [PMID: 34482482 DOI: 10.1007/s11845-021-02735-8] [Reference Citation Analysis]
33 Sollini M, Morbelli S, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Chiola S, Gelardi F, Chiti A. Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study. Eur J Nucl Med Mol Imaging 2021;48:3187-97. [PMID: 33677642 DOI: 10.1007/s00259-021-05294-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
34 Fratta Pasini AM, Stranieri C, Cominacini L, Mozzini C. Potential Role of Antioxidant and Anti-Inflammatory Therapies to Prevent Severe SARS-Cov-2 Complications. Antioxidants (Basel) 2021;10:272. [PMID: 33578849 DOI: 10.3390/antiox10020272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
35 Greco M, Suppressa S, Lazzari RA, Sicuro F, Catanese C, Lobreglio G. sFlt-1 and CA 15.3 are indicators of endothelial damage and pulmonary fibrosis in SARS-CoV-2 infection. Sci Rep 2021;11:19979. [PMID: 34620968 DOI: 10.1038/s41598-021-99470-y] [Reference Citation Analysis]
36 Angeli F, Verdecchia P, Reboldi G. Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patients. Expert Opin Pharmacother 2021;:1-8. [PMID: 34634987 DOI: 10.1080/14656566.2021.1990264] [Reference Citation Analysis]
37 Lichtenberger LM, Szabo S. A closer look at endothelial injury-induced platelet hyperactivity and the use of aspirin in the treatment of COVID infection. Inflammopharmacology 2022. [PMID: 35729443 DOI: 10.1007/s10787-022-01015-w] [Reference Citation Analysis]
38 Fortini F, Vieceli Dalla Sega F, Marracino L, Severi P, Rapezzi C, Rizzo P, Ferrari R. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 2021;9:997. [PMID: 34440201 DOI: 10.3390/biomedicines9080997] [Reference Citation Analysis]
39 Dikken JL, Maat APWM, Wolf JL, Endeman H, Hoek RAS, Bogers AJJC, Mahtab EAF. Organizing Pneumonia and Microvascular Fibrosis as Late Sequelae after a COVID-19 Infection. A Case Report. Surgeries 2021;2:190-8. [DOI: 10.3390/surgeries2020020] [Reference Citation Analysis]
40 Mallow PJ, Fedson DS. Non-traditional Use of HEOR To Identify Host Response Treatments During a Pandemic. JHEOR 2021;8:125-6. [DOI: 10.36469/jheor.2021.24591] [Reference Citation Analysis]
41 Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol 2022;23:194-202. [PMID: 35105985 DOI: 10.1038/s41590-021-01104-y] [Cited by in Crossref: 61] [Cited by in F6Publishing: 27] [Article Influence: 61.0] [Reference Citation Analysis]
42 Kharaeva Z, Shokarova A, Shomakhova Z, Ibragimova G, Trakhtman P, Trakhtman I, Chung J, Mayer W, De Luca C, Korkina L. Fermented Carica papaya and Morinda citrifolia as Perspective Food Supplements for the Treatment of Post-COVID Symptoms: Randomized Placebo-Controlled Clinical Laboratory Study. Nutrients 2022;14:2203. [PMID: 35684003 DOI: 10.3390/nu14112203] [Reference Citation Analysis]
43 Martynov MY, Bogolepova AN, Yasamanova AN. [Endothelial dysfunction in COVID- 19 and cognitive impairment]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:93-9. [PMID: 34283537 DOI: 10.17116/jnevro202112106193] [Reference Citation Analysis]
44 Pipe SW, Kaczmarek R, Srivastava A, Pierce GF, Makris M, Hermans C; Interim Guidance., Coagulation Products Safety, Supply and Access (CPSSA) Committee of the World Federation of Hemophilia. Management of COVID-19-associated coagulopathy in persons with haemophilia. Haemophilia 2021;27:41-8. [PMID: 33216448 DOI: 10.1111/hae.14191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
45 Bauer P, Kraushaar L, Dörr O, Keranov S, Nef H, Hamm CW, Most A. Vascular alterations among male elite athletes recovering from SARS-CoV-2 infection. Sci Rep 2022;12:8655. [PMID: 35606543 DOI: 10.1038/s41598-022-12734-z] [Reference Citation Analysis]
46 Li S, Liu S, Chen RA, Huang M, Fung TS, Liu DX. Activation of the MKK3-p38-MK2-ZFP36 Axis by Coronavirus Infection Restricts the Upregulation of AU-Rich Element-Containing Transcripts in Proinflammatory Responses. J Virol 2022;96:e0208621. [PMID: 34985993 DOI: 10.1128/jvi.02086-21] [Reference Citation Analysis]
47 Karsli E, Sabirli R, Altintas E, Canacik O, Sabirli GT, Kaymaz B, Kurt Ö, Koseler A. Soluble P-selectin as a potential diagnostic and prognostic biomarker for COVID-19 disease: A case-control study. Life Sci 2021;277:119634. [PMID: 34015287 DOI: 10.1016/j.lfs.2021.119634] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
48 Qin Z, Liu F, Blair R, Wang C, Yang H, Mudd J, Currey JM, Iwanaga N, He J, Mi R, Han K, Midkiff CC, Alam MA, Aktas BH, Heide RSV, Veazey R, Piedimonte G, Maness NJ, Ergün S, Mauvais-Jarvis F, Rappaport J, Kolls JK, Qin X. Endothelial cell infection and dysfunction, immune activation in severe COVID-19. Theranostics 2021;11:8076-91. [PMID: 34335981 DOI: 10.7150/thno.61810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 14.0] [Reference Citation Analysis]
49 Ristic-Medic D, Petrovic S, Arsic A, Vucic V. Liver disease and COVID-19: The link with oxidative stress, antioxidants and nutrition. World J Gastroenterol 2021; 27(34): 5682-5699 [PMID: 34629794 DOI: 10.3748/wjg.v27.i34.5682] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
50 Che Mohd Nassir CMN, Zolkefley MKI, Ramli MD, Norman HH, Abdul Hamid H, Mustapha M. Neuroinflammation and COVID-19 Ischemic Stroke Recovery—Evolving Evidence for the Mediating Roles of the ACE2/Angiotensin-(1–7)/Mas Receptor Axis and NLRP3 Inflammasome. IJMS 2022;23:3085. [DOI: 10.3390/ijms23063085] [Reference Citation Analysis]
51 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations. Res Sq 2021:rs. [PMID: 33564755 DOI: 10.21203/rs.3.rs-192099/v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
52 Norton CK, Brown A, Benedetto HN, Granitto M. The "Heart" of COVID-19: Brugada Syndrome and Post-SARS-CoV-2 Virus Cardiac Nursing Care. Adv Emerg Nurs J 2022;44:220-8. [PMID: 35900243 DOI: 10.1097/TME.0000000000000417] [Reference Citation Analysis]
53 Navarro-Martínez S, Diez Ares JÁ, Peris Tomás N, Gonzálvez Guardiola P, Pérez-Rubio Á. Superior mesenteric vein thrombosis as the only manifestation of SARS-CoV-2 infection. Cir Esp (Engl Ed) 2021:S0009-739X(21)00110-X. [PMID: 33849706 DOI: 10.1016/j.ciresp.2021.03.007] [Reference Citation Analysis]
54 Zarkovic N, Jakovcevic A, Mataic A, Jaganjac M, Vukovic T, Waeg G, Zarkovic K. Post-mortem Findings of Inflammatory Cells and the Association of 4-Hydroxynonenal with Systemic Vascular and Oxidative Stress in Lethal COVID-19. Cells 2022;11:444. [DOI: 10.3390/cells11030444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Caccuri F, Bugatti A, Zani A, De Palma A, Di Silvestre D, Manocha E, Filippini F, Messali S, Chiodelli P, Campisi G, Fiorentini S, Facchetti F, Mauri P, Caruso A. SARS-CoV-2 Infection Remodels the Phenotype and Promotes Angiogenesis of Primary Human Lung Endothelial Cells. Microorganisms 2021;9:1438. [PMID: 34361874 DOI: 10.3390/microorganisms9071438] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Vieceli Dalla Sega F, Fortini F, Spadaro S, Ronzoni L, Zucchetti O, Manfrini M, Mikus E, Fogagnolo A, Torsani F, Pavasini R, Marracino L, Verri M, Morandi L, D'Aniello E, Volta CA, Campo G, Ferrari R, Rizzo P, Contoli M. Time course of endothelial dysfunction markers and mortality in COVID-19 patients: A pilot study. Clin Transl Med 2021;11:e283. [PMID: 33784001 DOI: 10.1002/ctm2.283] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
57 Hollenberg MD, Epstein M. The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets. Kidney International Supplements 2022;12:48-62. [DOI: 10.1016/j.kisu.2021.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
58 Ernzen K, Trask AJ, Peeples ME, Garg V, Zhao MT. Human Stem Cell Models of SARS-CoV-2 Infection in the Cardiovascular System. Stem Cell Rev Rep 2021. [PMID: 34365591 DOI: 10.1007/s12015-021-10229-4] [Reference Citation Analysis]
59 Sherratt SCR, Libby P, Bhatt DL, Mason RP. A biological rationale for the disparate effects of omega-3 fatty acids on cardiovascular disease outcomes. Prostaglandins Leukot Essent Fatty Acids 2022;182:102450. [PMID: 35690002 DOI: 10.1016/j.plefa.2022.102450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 di Candia AM, de Avila DX, Moreira GR, Villacorta H, Maisel AS. Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases. American Heart Journal Plus: Cardiology Research and Practice 2021;9:100046. [DOI: 10.1016/j.ahjo.2021.100046] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Ambrosino P, Calcaterra IL, Mosella M, Formisano R, D’anna SE, Bachetti T, Marcuccio G, Galloway B, Mancini FP, Papa A, Motta A, Di Minno MND, Maniscalco M. Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target. Biomedicines 2022;10:812. [DOI: 10.3390/biomedicines10040812] [Reference Citation Analysis]
62 Costa TJ, Potje SR, Fraga-Silva TFC, da Silva-Neto JA, Barros PR, Rodrigues D, Machado MR, Martins RB, Santos-Eichler RA, Benatti MN, de Sá KSG, Almado CEL, Castro ÍA, Pontelli MC, Serra L, Carneiro FS, Becari C, Louzada-Junior P, Oliveira RDR, Zamboni DS, Arruda E, Auxiliadora-Martins M, Giachini FRC, Bonato VLD, Zachara NE, Bomfim GF, Tostes RC. Mitochondrial DNA and TLR9 activation contribute to SARS-CoV-2-induced endothelial cell damage. Vascul Pharmacol 2021;142:106946. [PMID: 34838735 DOI: 10.1016/j.vph.2021.106946] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
63 Kite TA, Ludman PF, Gale CP, Wu J, Caixeta A, Mansourati J, Sabate M, Jimenez-Quevedo P, Candilio L, Sadeghipour P, Iniesta AM, Hoole SP, Palmer N, Ariza-Solé A, Namitokov A, Escutia-Cuevas HH, Vincent F, Tica O, Ngunga M, Meray I, Morrow A, Arefin MM, Lindsay S, Kazamel G, Sharma V, Saad A, Sinagra G, Sanchez FA, Roik M, Savonitto S, Vavlukis M, Sangaraju S, Malik IS, Kean S, Curzen N, Berry C, Stone GW, Gersh BJ, Gershlick AH; International COVID-ACS Registry Investigators. International Prospective Registry of Acute Coronary Syndromes in Patients With COVID-19. J Am Coll Cardiol 2021;77:2466-76. [PMID: 34016259 DOI: 10.1016/j.jacc.2021.03.309] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
64 Furqan MM, Verma BR, Cremer PC, Imazio M, Klein AL. Pericardial Diseases in COVID19: a Contemporary Review. Curr Cardiol Rep 2021;23:90. [PMID: 34081219 DOI: 10.1007/s11886-021-01519-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Aydın E, Kant A, Yilmaz G. Evaluation of the cardio-ankle vascular index in COVID-19 patients. Rev Assoc Med Bras (1992) 2021:S0104-42302021005012202. [PMID: 34909966 DOI: 10.1590/1806-9282.20210781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Šikić J, Planinić Z, Matišić V, Friščić T, Molnar V, Jagačić D, Vujičić L, Tudorić N, Postružin Gršić L, Ljubičić Đ, Primorac D. COVID-19: The Impact on Cardiovascular System. Biomedicines 2021;9:1691. [PMID: 34829920 DOI: 10.3390/biomedicines9111691] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Birnhuber A, Fliesser E, Gorkiewicz G, Zacharias M, Seeliger B, David S, Welte T, Schmidt J, Olschewski H, Wygrecka M, Kwapiszewska G. Between inflammation and thrombosis - endothelial cells in COVID-19. Eur Respir J 2021:2100377. [PMID: 33958433 DOI: 10.1183/13993003.00377-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Liao L, Gong L, Zhou M, Xue X, Li Y, Peng C. Leonurine Ameliorates Oxidative Stress and Insufficient Angiogenesis by Regulating the PI3K/Akt-eNOS Signaling Pathway in H2O2-Induced HUVECs. Oxid Med Cell Longev 2021;2021:9919466. [PMID: 34394836 DOI: 10.1155/2021/9919466] [Reference Citation Analysis]
69 Won T, Wood MK, Hughes DM, Talor MV, Ma Z, Schneider J, Skinner JT, Asady B, Goerlich E, Halushka MK, Hays AG, Kim DH, Parikh CR, Rosenberg AZ, Coppens I, Johns RA, Gilotra NA, Hooper JE, Pekosz A, Čiháková D. Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs. EBioMedicine 2022;75:103812. [PMID: 35033854 DOI: 10.1016/j.ebiom.2022.103812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Nagai M, Förster CY. Day-to-day blood pressure variability in COVID-19: A biomarker of disrupted central autonomic network. J Clin Hypertens (Greenwich) 2022. [PMID: 35129297 DOI: 10.1111/jch.14438] [Reference Citation Analysis]
71 Kovach CP, Perman SM. Impact of the COVID-19 pandemic on cardiac arrest systems of care. Curr Opin Crit Care 2021;27:239-45. [PMID: 33783396 DOI: 10.1097/MCC.0000000000000817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Søraas A, Kalleberg KT, Dahl JA, Søraas CL, Myklebust TÅ, Axelsen E, Lind A, Bævre-Jensen R, Jørgensen SB, Istre MS, Kjetland EF, Ursin G. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PLoS One 2021;16:e0256142. [PMID: 34437579 DOI: 10.1371/journal.pone.0256142] [Reference Citation Analysis]
73 Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GYH, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B. Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;78:1635-54. [PMID: 34649702 DOI: 10.1016/j.jacc.2021.08.021] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Osikomaiya B, Erinoso O, Wright KO, Odusola AO, Thomas B, Adeyemi O, Bowale A, Adejumo O, Falana A, Abdus-Salam I, Ogboye O, Osibogun A, Abayomi A. 'Long COVID': persistent COVID-19 symptoms in survivors managed in Lagos State, Nigeria. BMC Infect Dis 2021;21:304. [PMID: 33765941 DOI: 10.1186/s12879-020-05716-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
75 Albasheer OB, Almutairi HA, Almalki FM, Malaka HM. Massive Arterial Cerebral Thrombosis in a 59-year old Female Patient With Severe COVID-19. Cureus 2021;13:e15553. [PMID: 34277178 DOI: 10.7759/cureus.15553] [Reference Citation Analysis]
76 Pal N, Weitzel NS, Kertai MD. A Change of Tide or the Beginning of the End: COVID-19. Semin Cardiothorac Vasc Anesth 2021;25:5-10. [PMID: 33554769 DOI: 10.1177/1089253221989132] [Reference Citation Analysis]
77 Siddiqi HK, Libby P, Ridker PM. COVID-19 - A vascular disease. Trends Cardiovasc Med. 2021;31:1-5. [PMID: 33068723 DOI: 10.1016/j.tcm.2020.10.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 21.0] [Reference Citation Analysis]
78 Gorna R, MacDermott N, Rayner C, O'Hara M, Evans S, Agyen L, Nutland W, Rogers N, Hastie C. Long COVID guidelines need to reflect lived experience. Lancet 2021;397:455-7. [PMID: 33357467 DOI: 10.1016/S0140-6736(20)32705-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 12.5] [Reference Citation Analysis]
79 Queisser KA, Mellema RA, Middleton EA, Portier I, Manne BK, Denorme F, Beswick EJ, Rondina MT, Campbell RA, Petrey AC. COVID-19 generates hyaluronan fragments that directly induce endothelial barrier dysfunction. JCI Insight 2021:147472. [PMID: 34314391 DOI: 10.1172/jci.insight.147472] [Reference Citation Analysis]
80 Bertoletti L, Bikdeli B, Zuily S, Blondon M, Mismetti P. Thromboprophylaxis strategies to improve the prognosis of COVID-19. Vascul Pharmacol 2021;139:106883. [PMID: 34091065 DOI: 10.1016/j.vph.2021.106883] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Orlowski S, Mourad JJ, Gallo A, Bruckert E. Coronaviruses, cholesterol and statins: Involvement and application for Covid-19. Biochimie 2021;189:51-64. [PMID: 34153377 DOI: 10.1016/j.biochi.2021.06.005] [Reference Citation Analysis]
82 Hajouli S. A 29-Year-Old Man with COVID-19 Pneumonia, Heart Failure-Reduced Ejection Fraction, and Atrial Fibrillation with a Father and 2 Grandparents Who Were Positive for SARS-CoV-2 Infection. Am J Case Rep 2021;22:e933163. [PMID: 34294675 DOI: 10.12659/AJCR.933163] [Reference Citation Analysis]
83 Santoro L, Falsetti L, Zaccone V, Nesci A, Tosato M, Giupponi B, Savastano MC, Moroncini G, Gasbarrini A, Landi F, Santoliquido A, On Behalf Of Gemelli Against Covid-Post-Acute Care Study Group. Impaired Endothelial Function in Convalescent Phase of COVID-19: A 3 Month Follow Up Observational Prospective Study. J Clin Med 2022;11:1774. [PMID: 35407382 DOI: 10.3390/jcm11071774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
84 Dai J, Teng X, Jin S, Wu Y. The Antiviral Roles of Hydrogen Sulfide by Blocking the Interaction between SARS-CoV-2 and Its Potential Cell Surface Receptors. Oxid Med Cell Longev 2021;2021:7866992. [PMID: 34497683 DOI: 10.1155/2021/7866992] [Reference Citation Analysis]
85 Daher J. Endothelial dysfunction and COVID-19 (Review). Biomed Rep 2021;15:102. [PMID: 34667599 DOI: 10.3892/br.2021.1478] [Reference Citation Analysis]
86 Cimmino G, Conte S, Morello M, Pellegrino G, Marra L, Morello A, Nicoletti G, De Rosa G, Golino P, Cirillo P. Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection? JCDD 2022;9:27. [DOI: 10.3390/jcdd9010027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
87 Ali L, Mohammed I, Janjua I, Naeem M, Adeli G, Elalamy O, Alhatou M, Akhtar N, Canibano B, Iqrar A. Acute Myocardial Injury and Rhabdomyolysis in COVID-19 Patients: Incidence and Mortality. Cureus 2021;13:e18899. [PMID: 34804738 DOI: 10.7759/cureus.18899] [Reference Citation Analysis]
88 Vuorio A, Strandberg TE, Raal F, Santos RD, Kovanen PT. Familial hypercholesterolemia and COVID-19: A menacing but treatable vasculopathic condition. Atheroscler Plus 2021;43:3-6. [PMID: 34622243 DOI: 10.1016/j.athplu.2021.08.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury. Am J Pathol 2021;191:1374-84. [PMID: 34033751 DOI: 10.1016/j.ajpath.2021.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
90 Wang SC, Wang YF. Cardiovascular protective properties of oxytocin against COVID-19. Life Sci 2021;270:119130. [PMID: 33513400 DOI: 10.1016/j.lfs.2021.119130] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
91 Bergamaschi L, D'Angelo EC, Paolisso P, Toniolo S, Fabrizio M, Angeli F, Donati F, Magnani I, Rinaldi A, Bartoli L, Chiti C, Biffi M, Pizzi C, Viale P, Galié N. The value of ECG changes in risk stratification of COVID-19 patients. Ann Noninvasive Electrocardiol 2021;26:e12815. [PMID: 33512742 DOI: 10.1111/anec.12815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 Terentes-Printzios D, Gardikioti V, Solomou E, Emmanouil E, Gourgouli I, Xydis P, Christopoulou G, Georgakopoulos C, Dima I, Miliou A, Lazaros G, Pirounaki M, Tsioufis K, Vlachopoulos C. The effect of an mRNA vaccine against COVID-19 on endothelial function and arterial stiffness. Hypertens Res 2022. [PMID: 35273351 DOI: 10.1038/s41440-022-00876-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
93 Vuorio A, Raal F, Kaste M, Kovanen PT. Familial hypercholesterolaemia and COVID-19: A two-hit scenario for endothelial dysfunction amenable to treatment. Atherosclerosis 2021;320:53-60. [PMID: 33540179 DOI: 10.1016/j.atherosclerosis.2021.01.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
94 Hossain MA, Kim J. Possibility as role of ginseng and ginsenosides on inhibiting the heart disease of COVID-19: A systematic review. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.01.003] [Reference Citation Analysis]
95 Roberts I, Wright Muelas M, Taylor JM, Davison AS, Xu Y, Grixti JM, Gotts N, Sorokin A, Goodacre R, Kell DB. Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics 2021;18:6. [PMID: 34928464 DOI: 10.1007/s11306-021-01859-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Dominguez LJ, Veronese N, Guerrero-Romero F, Barbagallo M. Magnesium in Infectious Diseases in Older People. Nutrients 2021;13:E180. [PMID: 33435521 DOI: 10.3390/nu13010180] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
97 Kovacs-Kasa A, Zaied AA, Leanhart S, Koseoglu M, Sridhar S, Lucas R, Fulton DJ, Vazquez JA, Annex BH. Elevated Cytokine Levels in Plasma of Patients with SARS-CoV-2 Do Not Contribute to Pulmonary Microvascular Endothelial Permeability. Microbiol Spectr 2022;:e0167121. [PMID: 35171047 DOI: 10.1128/spectrum.01671-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Zifkos K, Dubois C, Schäfer K. Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence. Int J Mol Sci 2021;22:9317. [PMID: 34502228 DOI: 10.3390/ijms22179317] [Reference Citation Analysis]
99 Goonewardena SN, Grushko OG, Wells J, Herty L, Rosenson RS, Haus JM, Hummel SL. Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients. Cardiovasc Drugs Ther 2021. [PMID: 34792686 DOI: 10.1007/s10557-021-07288-7] [Reference Citation Analysis]
100 Muhl L, He L, Sun Y, Andaloussi Mäe M, Pietilä R, Liu J, Genové G, Zhang L, Xie Y, Leptidis S, Mocci G, Stritt S, Osman A, Anisimov A, Hemanthakumar KA, Räsänen M, Hansson EM, Björkegren J, Vanlandewijck M, Blomgren K, Mäkinen T, Peng XR, Hu Y, Ernfors P, Arnold TD, Alitalo K, Lendahl U, Betsholtz C. The SARS-CoV-2 receptor ACE2 is expressed in mouse pericytes but not endothelial cells: Implications for COVID-19 vascular research. Stem Cell Reports 2022:S2213-6711(22)00149-7. [PMID: 35452595 DOI: 10.1016/j.stemcr.2022.03.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Imoto H, Yoshioka S, Nakagawa D, Hasegawa K, Kuroda H, Hasuike T, Doi A, Kusumoto T, Ishikawa T. Cold agglutinin anti-I antibodies in two patients with COVID-19. J Clin Lab Anal 2022;:e24629. [PMID: 35917437 DOI: 10.1002/jcla.24629] [Reference Citation Analysis]
102 Esposito S, D'Abrosca G, Antolak A, Pedone PV, Isernia C, Malgieri G. Host and Viral Zinc-Finger Proteins in COVID-19. Int J Mol Sci 2022;23:3711. [PMID: 35409070 DOI: 10.3390/ijms23073711] [Reference Citation Analysis]
103 Elahi S. Hematopoietic responses to SARS-CoV-2 infection. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-022-04220-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
104 Mahboubi Mehrabani M, Karvandi MS, Maafi P, Doroudian M. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Rev Med Virol 2022;:e2334. [PMID: 35138001 DOI: 10.1002/rmv.2334] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
105 Bhattacharya J, Booy R, Casadevall A, Dela Cruz C, Fedson DS, Garcia JGN, Grohmann G, Hung IFN, Jacobson JR, Jennings LC, Kobzik L, Leligdowicz A, Liao JK, Martin JH, Musher DM, Serhan CN, Tashiro M. A practical treatment for COVID-19 and the next pandemic. Pharmacol Res Perspect 2022;10:e00988. [PMID: 35837790 DOI: 10.1002/prp2.988] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Qiang Z, Wang B, Garrett BC, Rainey RP, Superko HR. Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers. Curr Opin Cardiol 2021;36:367-73. [PMID: 33709980 DOI: 10.1097/HCO.0000000000000851] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
107 Chu R, van Eeden C, Suresh S, Sligl WI, Osman M, Cohen Tervaert JW. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis. Int J Mol Sci 2021;22:2967. [PMID: 33803997 DOI: 10.3390/ijms22062967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Fedson DS. Statin withdrawal and treating COVID-19 patients. Pharmacol Res Perspect 2021;9:e00861. [PMID: 34708573 DOI: 10.1002/prp2.861] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Lucas R, Hadizamani Y, Enkhbaatar P, Csanyi G, Caldwell RW, Hundsberger H, Sridhar S, Lever AA, Hudel M, Ash D, Ushio-Fukai M, Fukai T, Chakraborty T, Verin A, Eaton DC, Romero M, Hamacher J. Dichotomous Role of Tumor Necrosis Factor in Pulmonary Barrier Function and Alveolar Fluid Clearance. Front Physiol 2021;12:793251. [PMID: 35264975 DOI: 10.3389/fphys.2021.793251] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
110 Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, Hanghicel P, Sitar-Taut A, Suharoschi R, Vulturar R, Cozma A. Endothelial Dysfunction, Inflammation, and Oxidative Stress in COVID-19-Mechanisms and Therapeutic Targets. Oxid Med Cell Longev 2021;2021:8671713. [PMID: 34457119 DOI: 10.1155/2021/8671713] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
111 Aziz F, Behrendt CA, Sullivan K, Beck AW, Beiles CB, Boyle JR, Mani K, Benson RA, Wohlauer MV, Khashram M, Jorgensen JE, Lemmon GW. The impact of COVID-19 pandemic on vascular registries and clinical trials. Semin Vasc Surg 2021;34:28-36. [PMID: 34144744 DOI: 10.1053/j.semvascsurg.2021.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Johnson JN, Loriaux DB, Jenista E, Kim HW, Baritussio A, De Garate Iparraguirre E, Bucciarelli-Ducci C, Denny V, O'Connor B, Siddiqui S, Fujikura K, Benton CW, Weinsaft JW, Kochav J, Kim J, Madamanchi C, Steigner M, Kwong R, Chango-Azanza D, Chapa M, Rosales-Uvera S, Sitwala P, Filev P, Sahu A, Craft J, Punnakudiyil GJ, Jayam V, Shams F, Hughes SG, Lee JCY, Hulten EA, Steel KE, Chen SSM. Society for Cardiovascular Magnetic Resonance 2021 cases of SCMR and COVID-19 case collection series. J Cardiovasc Magn Reson 2022;24:42. [PMID: 35787291 DOI: 10.1186/s12968-022-00872-2] [Reference Citation Analysis]
113 Estruch R, Ruilope LM, Cosentino F. The year in cardiovascular medicine 2020: epidemiology and prevention. Eur Heart J 2021;42:813-21. [PMID: 33388753 DOI: 10.1093/eurheartj/ehaa1062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
114 Festa J, Singh H, Hussain A, Da Boit M. Elderberries as a potential supplement to improve vascular function in a SARS-CoV-2 environment. J Food Biochem 2022;:e14091. [PMID: 35118699 DOI: 10.1111/jfbc.14091] [Reference Citation Analysis]
115 Villacorta H, Pickering JW, Horiuchi Y, Olim M, Coyne C, Maisel AS, Than MP. Machine learning with D-dimer in the risk stratification for pulmonary embolism: a derivation and internal validation study. Eur Heart J Acute Cardiovasc Care 2021:zuab089. [PMID: 34697635 DOI: 10.1093/ehjacc/zuab089] [Reference Citation Analysis]
116 Choudry FA, Mathur A, Jones DA. Editorial commentary: Understanding thrombosis in COVID-19 - A long way to go. Trends Cardiovasc Med 2021;31:161-2. [PMID: 33383172 DOI: 10.1016/j.tcm.2020.12.006] [Reference Citation Analysis]
117 Bérezné A, Bougon D, Blanc-Jouvan F, Gendron N, Janssen C, Muller M, Bertil S, Desvard F, Presot I, Terrier B, Chocron R, Sanchez O, Helley D, Smadja DM. Deterioration of vaccine-induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay. Res Pract Thromb Haemost 2021;5:e12572. [PMID: 34485807 DOI: 10.1002/rth2.12572] [Reference Citation Analysis]
118 Tankere P, Cottenet J, Tubert-Bitter P, Mariet AS, Beltramo G, Cadranel J, Piroth L, Bonniaud P, Quantin C. Impact of COVID-19 and lockdowns on pulmonary embolism in hospitalized patients in France: a nationwide study. Respir Res 2021;22:298. [PMID: 34801044 DOI: 10.1186/s12931-021-01887-6] [Reference Citation Analysis]
119 De Michieli L, Jaffe AS, Sandoval Y. Use and Prognostic Implications of Cardiac Troponin in COVID-19. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Soma P, Bester J. Pathophysiological Changes in Erythrocytes Contributing to Complications of Inflammation and Coagulation in COVID-19. Front Physiol 2022;13:899629. [DOI: 10.3389/fphys.2022.899629] [Reference Citation Analysis]
121 Byttebier G, Belmans L, Alexander M, Saxberg BEH, De Spiegeleer B, De Spiegeleer A, Devreker N, Van Praet JT, Vanhove K, Reybrouck R, Wynendaele E, Fedson DS. Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs. Hum Vaccin Immunother 2021;17:2841-50. [PMID: 34047686 DOI: 10.1080/21645515.2021.1920271] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
122 Fernández S, Palomo M, Molina P, Díaz-Ricart M, Escolar G, Téllez A, Seguí F, Ventosa H, Torramade-Moix S, Rovira M, Carreras E, Nicolás JM, Castro P. Progressive endothelial cell damage in correlation with sepsis severity. Defibrotide as a contender. J Thromb Haemost 2021;19:1948-58. [PMID: 33872468 DOI: 10.1111/jth.15343] [Reference Citation Analysis]
123 Sfera A, Osorio C, Zapata Martín Del Campo CM, Pereida S, Maurer S, Maldonado JC, Kozlakidis Z. Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis. Front Cell Neurosci 2021;15:673217. [PMID: 34248502 DOI: 10.3389/fncel.2021.673217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
124 Tiscia G, Favuzzi G, De Laurenzo A, Cappucci F, Fischetti L, Colaizzo D, Chinni E, Florio L, Miscio G, Piscitelli AP, Mastroianno M, Grandone E. The Prognostic Value of ADAMTS-13 and von Willebrand Factor in COVID-19 Patients: Prospective Evaluation by Care Setting. Diagnostics (Basel) 2021;11:1648. [PMID: 34573989 DOI: 10.3390/diagnostics11091648] [Reference Citation Analysis]
125 Orendáčová M, Kvašňák E. Possible Mechanisms Underlying Neurological Post-COVID Symptoms and Neurofeedback as a Potential Therapy. Front Hum Neurosci 2022;16:837972. [DOI: 10.3389/fnhum.2022.837972] [Reference Citation Analysis]
126 Buja LM, Stone JR. A novel coronavirus meets the cardiovascular system: Society for Cardiovascular Pathology Symposium 2021. Cardiovasc Pathol 2021;53:107336. [PMID: 33895311 DOI: 10.1016/j.carpath.2021.107336] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
127 Rizvi AA, Janez A, Rizzo M. Cardiometabolic Alterations in the Interplay of COVID-19 and Diabetes: Current Knowledge and Future Avenues. Int J Mol Sci 2021;22:12311. [PMID: 34830193 DOI: 10.3390/ijms222212311] [Reference Citation Analysis]
128 Montiel V, Lobysheva I, Gérard L, Vermeersch M, Perez-Morga D, Castelein T, Mesland JB, Hantson P, Collienne C, Gruson D, van Dievoet MA, Persu A, Beauloye C, Dechamps M, Belkhir L, Robert A, Derive M, Laterre PF, Danser AHJ, Wittebole X, Balligand JL. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients. EBioMedicine 2022;77:103893. [PMID: 35219085 DOI: 10.1016/j.ebiom.2022.103893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
129 Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). J Transl Med 2021;19:162. [PMID: 33882940 DOI: 10.1186/s12967-021-02833-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
130 Cremer PC, Sheng CC, Sahoo D, Dugar S, Prada RA, Wang TKM, Hassan OKA, Hernandez-montfort J, Wolinsky DA, Culver DA, Rajendram P, Duggal A, Brennan DM, Wolski KE, Lincoff AM, Nissen SE, Menon V. Double-blind randomized proof-of-concept trial of canakinumab in patients with COVID-19 associated cardiac injury and heightened inflammation. European Heart Journal Open 2021;1:oeab002. [DOI: 10.1093/ehjopen/oeab002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
131 De Michieli L, Babuin L, Vigolo S, Berti De Marinis G, Lunardon A, Favretto F, Lobo R, Sandoval Y, Bryant SC, Donato D, Plebani M, Vettor R, Iliceto S, Cianci V, Jaffe AS. Using high sensitivity cardiac troponin values in patients with SARS-CoV-2 infection (COVID-19): The Padova experience. Clin Biochem 2021;90:8-14. [PMID: 33529580 DOI: 10.1016/j.clinbiochem.2021.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
132 Vella L, Giles JR, Baxter AE, Oldridge DA, Diorio C, Kuri-Cervantes L, Alanio C, Pampena MB, Wu JE, Chen Z, Huang YJ, Anderson EM, Gouma S, McNerney KO, Chase J, Burudpakdee C, Lee JH, Apostolidis SA, Huang AC, Mathew D, Kuthuru O, Goodwin EC, Weirick ME, Bolton MJ, Arevalo CP, Ramos A, Jasen C, Giannini HM, DAndrea K, Meyer NJ, Behrens EM, Bassiri H, Hensley SE, Henrickson SE, Teachey DT, Betts MR, Wherry EJ. Deep Immune Profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. medRxiv 2020:2020. [PMID: 32995826 DOI: 10.1101/2020.09.25.20201863] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
133 Jover E, Matilla L, Garaikoetxea M, Fernández-Celis A, Muntendam P, Jaisser F, Rossignol P, López-Andrés N. Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein. Biomedicines 2021;9:639. [PMID: 34204890 DOI: 10.3390/biomedicines9060639] [Reference Citation Analysis]
134 Rochette L, Ghibu S. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection. Int J Mol Sci 2021;22:7979. [PMID: 34360751 DOI: 10.3390/ijms22157979] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
135 Ilonzo N, Judelson D, Al-Jundi W, Etkin Y, O'Banion LA, Rivera A, Tinelli G, Bellosta R, Vouyouka A. A review of acute limb ischemia in COVID-positive patients. Semin Vasc Surg 2021;34:8-12. [PMID: 34144749 DOI: 10.1053/j.semvascsurg.2021.04.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
136 Bharmal M, Digrande K, Patel A, Shavelle DM, Bosson N. Impact of COVID-19 Pandemic on Cardiac Arrest and Emergency Care. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.009] [Reference Citation Analysis]
137 Biasco L, Klersy C, Beretta GS, Valgimigli M, Valotta A, Gabutti L, Bruna RD, Pagnamenta A, Tersalvi G, Ruinelli L, Artero A, Senatore G, Jüni P, Pedrazzini GB, Bäck M. Comparative frequency and prognostic impact of myocardial injury in hospitalized patients with COVID-19 and Influenza. European Heart Journal Open 2021;1:oeab025. [DOI: 10.1093/ehjopen/oeab025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
138 Vernon SD, Funk S, Bateman L, Stoddard GJ, Hammer S, Sullivan K, Bell J, Abbaszadeh S, Lipkin WI, Komaroff AL. Orthostatic Challenge Causes Distinctive Symptomatic, Hemodynamic and Cognitive Responses in Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Med 2022;9:917019. [DOI: 10.3389/fmed.2022.917019] [Reference Citation Analysis]
139 Marijon E, Karam N, Jouven X. Cardiac arrest occurrence during successive waves of the COVID-19 pandemic: direct and indirect consequences. Eur Heart J 2021;42:1107-9. [PMID: 33543260 DOI: 10.1093/eurheartj/ehab051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Gauchel N, Krauel K, Hamad MA, Bode C, Duerschmied D. Thromboinflammation as a Driver of Venous Thromboembolism. Hamostaseologie 2021;41:428-32. [PMID: 34942655 DOI: 10.1055/a-1661-0257] [Reference Citation Analysis]
141 Gorshkov K, Chen CZ, Bostwick R, Rasmussen L, Tran BN, Cheng YS, Xu M, Pradhan M, Henderson M, Zhu W, Oh E, Susumu K, Wolak M, Shamim K, Huang W, Hu X, Shen M, Klumpp-Thomas C, Itkin Z, Shinn P, Carlos de la Torre J, Simeonov A, Michael SG, Hall MD, Lo DC, Zheng W. The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules. ACS Infect Dis 2021;7:1389-408. [PMID: 33346633 DOI: 10.1021/acsinfecdis.0c00349] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 32.0] [Reference Citation Analysis]
142 Szekely Y, Lichter Y, Sadon S, Lupu L, Taieb P, Banai A, Sapir O, Granot Y, Hochstadt A, Friedman S, Laufer-Perl M, Banai S, Topilsky Y. Cardiorespiratory Abnormalities in Patients Recovering from Coronavirus Disease 2019. J Am Soc Echocardiogr 2021;34:1273-1284.e9. [PMID: 34508837 DOI: 10.1016/j.echo.2021.08.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
143 Singh M, Pushpakumar S, Bard N, Zheng Y, Homme RP, Mokshagundam SPL, Tyagi SC. Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers. Mol Cell Biochem 2022. [PMID: 35731343 DOI: 10.1007/s11010-022-04487-0] [Reference Citation Analysis]
144 Kaklamanos A, Belogiannis K, Skendros P, Gorgoulis VG, Vlachoyiannopoulos PG, Tzioufas AG. COVID-19 Immunobiology: Lessons Learned, New Questions Arise. Front Immunol 2021;12:719023. [PMID: 34512643 DOI: 10.3389/fimmu.2021.719023] [Reference Citation Analysis]
145 Laubscher GJ, Lourens PJ, Venter C, Kell DB, Pretorius E. TEG®, Microclot and Platelet Mapping for Guiding Early Management of Severe COVID-19 Coagulopathy. J Clin Med 2021;10:5381. [PMID: 34830660 DOI: 10.3390/jcm10225381] [Reference Citation Analysis]
146 Bernatova I, Liskova S. Mechanisms Modified by (-)-Epicatechin and Taxifolin Relevant for the Treatment of Hypertension and Viral Infection: Knowledge from Preclinical Studies. Antioxidants (Basel) 2021;10:467. [PMID: 33809620 DOI: 10.3390/antiox10030467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Vladimirova-Kitova L, Kitov S, Ganev M, Chochkova-Bukova L. Case Report: Difficulties in the Treatment of a 12-Year-Old Patient With Homozygous Familial Hypercholesterolemia, Compound Heterozygous Form - 5 Years Follow-Up. Front Cardiovasc Med 2021;8:743341. [PMID: 34692794 DOI: 10.3389/fcvm.2021.743341] [Reference Citation Analysis]
148 Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med 2021:S1471-4914(21)00134-9. [PMID: 34175230 DOI: 10.1016/j.molmed.2021.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
149 ter Ellen BM, Niewold J, Flikweert A, Muller Kobold AC, Heeringa P, van Meurs M, Smit JM, van der Voort PHJ, Rodenhuis-zybert IA, Moser J. Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells In Vitro. Front Immunol 2022;13:879033. [DOI: 10.3389/fimmu.2022.879033] [Reference Citation Analysis]
150 O'Gallagher K, Shek A, Bean DM, Bendayan R, Papachristidis A, Teo JTH, Dobson RJB, Shah AM, Zakeri R. Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19. BMC Cardiovasc Disord 2021;21:327. [PMID: 34217220 DOI: 10.1186/s12872-021-02137-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Kurra NC, Sriram K, Gandrakota N, Nagarajan JS, Khasnavis S, Ramakrishnan M, Dalal S, Irfan SA, Khan S, Jk H, Patel D, Samudrala G. Frontliners on the Move: A Quantitative Analysis of the Prevalence of COVID-19 Reinfection Among Healthcare Workers. Cureus. [DOI: 10.7759/cureus.24652] [Reference Citation Analysis]
152 Constant O, Barthelemy J, Bolloré K, Tuaillon E, Gosselet F, Chable-Bessia C, Merida P, Muriaux D, Van de Perre P, Salinas S, Simonin Y. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects. Front Immunol 2021;12:697329. [PMID: 34386007 DOI: 10.3389/fimmu.2021.697329] [Reference Citation Analysis]
153 Ruzzenenti G, Maloberti A, Giani V, Biolcati M, Leidi F, Monticelli M, Grasso E, Cartella I, Palazzini M, Garatti L, Ughi N, Rossetti C, Epis OM, Giannattasio C; Covid-19 Niguarda Working Group. Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective. High Blood Press Cardiovasc Prev 2021. [PMID: 34173942 DOI: 10.1007/s40292-021-00464-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
154 Feldman DI, Wu KC, Hays AG, Marvel FA, Martin SS, Blumenthal RS, Sharma G. The Johns Hopkins Ciccarone Center's expanded 'ABC's approach to highlight 2020 updates in cardiovascular disease prevention. Am J Prev Cardiol 2021;6:100181. [PMID: 34327502 DOI: 10.1016/j.ajpc.2021.100181] [Reference Citation Analysis]
155 Gaddh M, Maier CL. Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center. JCO Oncol Pract 2021;:OP2001056. [PMID: 34019440 DOI: 10.1200/OP.20.01056] [Reference Citation Analysis]
156 Soehnlein O, Libby P. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov 2021;20:589-610. [PMID: 33976384 DOI: 10.1038/s41573-021-00198-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
157 Atif M, Naz F, Akhtar J, Imran M, Saleem S, Akram J, Imran M, Ullah MI. From Molecular Pathology of COVID 19 to Nigella Sativum as a Treatment Option: Scientific Based Evidence of Its Myth or Reality. Chin J Integr Med 2021. [PMID: 34586557 DOI: 10.1007/s11655-021-3311-z] [Reference Citation Analysis]
158 [DOI: 10.1101/2021.01.04.21249227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
159 Vuorio A, Kovanen PT. Statins as Adjuvant Therapy for COVID-19 to Calm the Stormy Immunothrombosis and Beyond. Front Pharmacol 2020;11:579548. [PMID: 33542685 DOI: 10.3389/fphar.2020.579548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
160 Farshidfar F, Koleini N, Ardehali H. Cardiovascular complications of COVID-19. JCI Insight 2021;6:148980. [PMID: 34061779 DOI: 10.1172/jci.insight.148980] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Degauque N, Haziot A, Brouard S, Mooney N. Endothelial cell, myeloid, and adaptive immune responses in SARS-CoV-2 infection. FASEB J 2021;35:e21577. [PMID: 33831263 DOI: 10.1096/fj.202100024R] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
162 Libby P. Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. Cells 2021;10:951. [PMID: 33924019 DOI: 10.3390/cells10040951] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
163 Jakstaite AM, Papathanasiou M, Lüdike P. Myokarditis und COVID-19: Wo stehen wir? Aktuelle Kardiologie 2021;10:27-31. [DOI: 10.1055/a-1314-9200] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Buja LM, Zhao B, McDonald M, Ottaviani G, Wolf DA. Commentary on the spectrum of cardiopulmonary pathology in COVID-19. Cardiovasc Pathol 2021;53:107339. [PMID: 33992734 DOI: 10.1016/j.carpath.2021.107339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
165 Sagris M, Theofilis P, Antonopoulos AS, Tsioufis C, Oikonomou E, Antoniades C, Crea F, Kaski JC, Tousoulis D. Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives. Int J Mol Sci 2021;22:6607. [PMID: 34205487 DOI: 10.3390/ijms22126607] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
166 Ackermann M, Werlein C, Länger F, Kühnel MP, Jonigk DD. [COVID-19: effects on the lungs and heart]. Pathologe 2021;42:164-71. [PMID: 33560456 DOI: 10.1007/s00292-021-00918-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
167 Potje SR, Costa TJ, Fraga-Silva TFC, Martins RB, Benatti MN, Almado CEL, de Sá KSG, Bonato VLD, Arruda E, Louzada-Junior P, Oliveira RDR, Zamboni DS, Becari C, Auxiliadora-Martins M, Tostes RC. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients. Life Sci 2021;276:119376. [PMID: 33781826 DOI: 10.1016/j.lfs.2021.119376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
168 Chakir M, El Jamili M, Boudhar Z, El Hattaoui M. Simultaneous acute myocardial infarction, bilateral pulmonary embolism, and acute ischaemic cerebral stroke, a delayed complication in a patient with COVID-19 infection: case report. Eur Heart J Case Rep 2021;5:ytab218. [PMID: 34189400 DOI: 10.1093/ehjcr/ytab218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
169 Jonmarker S, Litorell J, Dahlberg M, Stackelberg O, Everhov ÅH, Söderberg M, Rubenson-Wahlin R, Günther M, Mårtensson J, Hollenberg J, Joelsson-Alm E, Cronhjort M. An observational study of intermediate- or high-dose thromboprophylaxis for critically ill COVID-19 patients. Acta Anaesthesiol Scand 2022;66:365-74. [PMID: 34875111 DOI: 10.1111/aas.14013] [Reference Citation Analysis]
170 Silva ACV, Machado-Junior PAB, Anizelli LB, Stocco RB, Moura LAZ, Motta Junior JDS, Blume GG. Pulmonary thromboembolism in conjunction with intracavitary thrombus caused by severe acute respiratory syndrome coronavirus-2 infection in a patient living with human immunodeficiency virus. Rev Soc Bras Med Trop 2021;54:e01572021. [PMID: 34105629 DOI: 10.1590/0037-8682-0157-2021] [Reference Citation Analysis]
171 Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Dreyfus I, Kakavand H, Ariannejad H, Gupta A, Madhavan MV, Van Tassell BW, Jimenez D, Monreal M, Vaduganathan M, Fanikos J, Dixon DL, Piazza G, Parikh SA, Bhatt DL, Lip GY, Stone GW, Krumholz HM, Libby P, Goldhaber SZ, Bikdeli B. Lipid-Modulating Agents for Prevention or Treatment of COVID-19 in Randomized Trials. medRxiv 2021:2021. [PMID: 33972948 DOI: 10.1101/2021.05.03.21256468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Kałucka S, Kusideł E, Głowacka A, Oczoś P, Grzegorczyk-karolak I. Pre-Vaccination Stress, Post-Vaccination Adverse Reactions, and Attitudes towards Vaccination after Receiving the COVID-19 Vaccine among Health Care Workers. Vaccines 2022;10:401. [DOI: 10.3390/vaccines10030401] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
173 Ismail Z, Salabei JK, Stanger G, Asnake ZT, Frimer L, Smock A. Third-Degree Heart Block Associated With Saddle Pulmonary Embolism: A Rare Sequelae of COVID-19-Induced Hypercoagulable State. Cureus 2021;13:e16246. [PMID: 34381643 DOI: 10.7759/cureus.16246] [Reference Citation Analysis]
174 Sackner MA, Adams JA. Endothelial pulsatile shear stress is a backstop for COVID-19. Emerg Top Life Sci 2020;4:379-87. [PMID: 33200786 DOI: 10.1042/ETLS20200260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
175 Panigrahi S, Goswami T, Ferrari B, Antonelli CJ, Bazdar DA, Gilmore H, Freeman ML, Lederman MM, Sieg SF. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis. Microbiol Spectr 2021;:e0073521. [PMID: 34935423 DOI: 10.1128/Spectrum.00735-21] [Reference Citation Analysis]
176 Bruter AV, Korshunova DS, Kubekina MV, Sergiev PV, Kalinina AA, Ilchuk LA, Silaeva YY, Korshunov EN, Soldatov VO, Deykin AV. Novel transgenic mice with Cre-dependent co-expression of GFP and human ACE2: a safe tool for study of COVID-19 pathogenesis. Transgenic Res 2021. [PMID: 33855640 DOI: 10.1007/s11248-021-00249-8] [Reference Citation Analysis]
177 Orendáčová M, Kvašňák E. Effects of vaccination, new SARS-CoV-2 variants and reinfections on post-COVID-19 complications. Front Public Health 2022;10:903568. [DOI: 10.3389/fpubh.2022.903568] [Reference Citation Analysis]
178 Sastry S, Cuomo F, Muthusamy J. COVID-19 and thrombosis: The role of hemodynamics. Thrombosis Research 2022;212:51-7. [DOI: 10.1016/j.thromres.2022.02.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
179 Iglesias MJ, Kruse LD, Sanchez-Rivera L, Enge L, Dusart P, Hong MG, Uhlén M, Renné T, Schwenk JM, Bergstrom G, Odeberg J, Butler LM. Identification of Endothelial Proteins in Plasma Associated With Cardiovascular Risk Factors. Arterioscler Thromb Vasc Biol 2021;41:2990-3004. [PMID: 34706560 DOI: 10.1161/ATVBAHA.121.316779] [Reference Citation Analysis]
180 Talasaz AH, Sadeghipour P, Kakavand H, Aghakouchakzadeh M, Kordzadeh-Kermani E, Van Tassell BW, Gheymati A, Ariannejad H, Hosseini SH, Jamalkhani S, Sholzberg M, Monreal M, Jimenez D, Piazza G, Parikh SA, Kirtane AJ, Eikelboom JW, Connors JM, Hunt BJ, Konstantinides SV, Cushman M, Weitz JI, Stone GW, Krumholz HM, Lip GYH, Goldhaber SZ, Bikdeli B. Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review. J Am Coll Cardiol 2021;77:1903-21. [PMID: 33741176 DOI: 10.1016/j.jacc.2021.02.035] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 26.0] [Reference Citation Analysis]
181 Seo J, Kim D, Yun N, Kim D. Coronavirus Disease 2019-Associated Coagulopathy. Microorganisms 2022;10:1556. [DOI: 10.3390/microorganisms10081556] [Reference Citation Analysis]
182 Cordon-Cardo C, Pujadas E, Wajnberg A, Sebra R, Patel G, Firpo-Betancourt A, Fowkes M, Sordillo E, Paniz-Mondolfi A, Gregory J, Krammer F, Simon V, Isola L, Soon-Shiong P, Aberg JA, Fuster V, Reich DL. COVID-19: Staging of a New Disease. Cancer Cell 2020;38:594-7. [PMID: 33086031 DOI: 10.1016/j.ccell.2020.10.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
183 Saavedra JM. Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Physiology (Bethesda) 2021;36:160-73. [PMID: 33904788 DOI: 10.1152/physiol.00036.2020] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
184 Farkouh ME, Stone GW, Lala A, Bagiella E, Moreno PR, Nadkarni GN, Ben-Yehuda O, Granada JF, Dressler O, Tinuoye EO, Granada C, Bustamante J, Peyra C, Godoy LC, Palacios IF, Fuster V. Anticoagulation in Patients With COVID-19: JACC Review Topic of the Week. J Am Coll Cardiol 2022;79:917-28. [PMID: 35241226 DOI: 10.1016/j.jacc.2021.12.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
185 Sabel BA, Zhou W, Huber F, Schmidt F, Sabel K, Gonschorek A, Bilc M. Non-invasive brain microcurrent stimulation therapy of long-COVID-19 reduces vascular dysregulation and improves visual and cognitive impairment. Restor Neurol Neurosci 2021;39:393-408. [PMID: 34924406 DOI: 10.3233/RNN-211249] [Reference Citation Analysis]
186 Gambardella J, Santulli G. What is linking COVID-19 and endothelial dysfunction? Updates on nanomedicine and bioengineering from the 2020 AHA Scientific Sessions. Eur Heart J Cardiovasc Pharmacother 2021;7:e2-3. [PMID: 33377481 DOI: 10.1093/ehjcvp/pvaa145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
187 Ionescu M, Stoian AP, Rizzo M, Serban D, Nuzzo D, Mazilu L, Suceveanu AI, Dascalu AM, Parepa IR. The Role of Endothelium in COVID-19. Int J Mol Sci 2021;22:11920. [PMID: 34769350 DOI: 10.3390/ijms222111920] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Esposito L, Cancro FP, Silverio A, Di Maio M, Iannece P, Damato A, Alfano C, De Luca G, Vecchione C, Galasso G. COVID-19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives. Oxid Med Cell Longev 2021;2021:4936571. [PMID: 34484561 DOI: 10.1155/2021/4936571] [Reference Citation Analysis]
189 Devaux CA, Camoin-Jau L, Mege JL, Raoult D. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ? J Microbiol Immunol Infect 2021;54:37-45. [PMID: 33500211 DOI: 10.1016/j.jmii.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
190 Ma Z, Li X, Fan RLY, Yang KY, Ng CSH, Lau RWH, Wong RHL, Ng KK, Wang CC, Ye P, Fu Z, Chin AWH, Lai MYA, Huang Y, Tian XY, Poon LLM, Lui KO. A human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4. Stem Cell Reports 2022:S2213-6711(22)00059-5. [PMID: 35180397 DOI: 10.1016/j.stemcr.2022.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
191 Leucker TM, Osburn WO, Reventun P, Smith K, Claggett B, Kirwan BA, de Brouwer S, Williams MS, Gerstenblith G, Hager DN, Streiff MB, Solomon SD, Lowenstein CJ. Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial. JACC Basic Transl Sci 2021;6:935-45. [PMID: 34904132 DOI: 10.1016/j.jacbts.2021.09.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
192 Ursini F, Ciaffi J, Mancarella L, Lisi L, Brusi V, Cavallari C, D'Onghia M, Mari A, Borlandelli E, Faranda Cordella J, La Regina M, Viola P, Ruscitti P, Miceli M, De Giorgio R, Baldini N, Borghi C, Gasbarrini A, Iagnocco A, Giacomelli R, Faldini C, Landini MP, Meliconi R. Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open 2021;7:e001735. [PMID: 34426540 DOI: 10.1136/rmdopen-2021-001735] [Reference Citation Analysis]
193 Gusev E, Sarapultsev A, Hu D, Chereshnev V. Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes). Int J Mol Sci 2021;22:7582. [PMID: 34299201 DOI: 10.3390/ijms22147582] [Reference Citation Analysis]
194 Trimaille A, Marchandot B, Oulehri W, Carmona A, Vollmer O, Poindron V, Matsushita K, Sattler L, Grunebaum L, Korganow AS, Schini-Kerth V, Morel O. Transient endothelial injury and release of lupus anticoagulant in COVID-19. J Thromb Thrombolysis 2021. [PMID: 34047937 DOI: 10.1007/s11239-021-02485-5] [Reference Citation Analysis]
195 Stenmark KR, Frid MG, Gerasimovskaya E, Zhang H, McCarthy MK, Thurman JM, Morrison TE. Mechanisms of SARS-CoV-2-induced lung vascular disease: potential role of complement. Pulm Circ 2021;11:20458940211015799. [PMID: 34046161 DOI: 10.1177/20458940211015799] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
196 Villalba N, Baby S, Yuan SY. The Endothelial Glycocalyx as a Double-Edged Sword in Microvascular Homeostasis and Pathogenesis. Front Cell Dev Biol 2021;9:711003. [PMID: 34336864 DOI: 10.3389/fcell.2021.711003] [Reference Citation Analysis]
197 Losso JN. The Potential of Dietary Bioactive Compounds against SARS-CoV-2 and COVID-19-Induced Endothelial Dysfunction. Molecules 2022;27:1623. [PMID: 35268723 DOI: 10.3390/molecules27051623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
198 Caro-Codón J, Lip GYH, Rey JR, Iniesta AM, Rosillo SO, Castrejon-Castrejon S, Rodriguez-Sotelo L, Garcia-Veas JM, Marco I, Martinez LA, Martin-Polo L, Merino C, Martinez-Cossiani M, Buño A, Gonzalez-Valle L, Herrero A, Lopez-de-Sa E, Merino JL. Prediction of thromboembolic events and mortality by the CHADS2 and the CHA2DS2-VASc in COVID-19. Europace 2021;23:937-47. [PMID: 33564822 DOI: 10.1093/europace/euab015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
199 Lüscher TF. Understanding COVID-19: in the end it is the endothelium-what else? Eur Heart J 2020;41:3023-7. [PMID: 33216863 DOI: 10.1093/eurheartj/ehaa706] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
200 Taieb P, Szekely Y, Lupu L, Ghantous E, Borohovitz A, Sadon S, Lichter Y, Ben-Gal Y, Banai A, Hochstadt A, Merdler I, Sapir O, Granot Y, Laufer-Perl M, Banai S, Topilsky Y. Risk prediction in patients with COVID-19 based on haemodynamic assessment of left and right ventricular function. Eur Heart J Cardiovasc Imaging 2021;22:1241-54. [PMID: 34453517 DOI: 10.1093/ehjci/jeab169] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
201 Evans P, Wojta J, Hoefer IE, Waltenberger J, Guzik T, Badimon L, Weber C. The year in basic vascular biology research: from mechanoreceptors and neutrophil extracellular traps to smartphone data and omics. Cardiovasc Res 2021;117:1814-22. [PMID: 33744925 DOI: 10.1093/cvr/cvab105] [Reference Citation Analysis]
202 Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh SS, Chello M, Bouzguenda A, Copie X. Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review. Biomedicines 2022;10:702. [DOI: 10.3390/biomedicines10030702] [Reference Citation Analysis]
203 Cruz Rodriguez JB, Lange RA, Mukherjee D. Gamut of cardiac manifestations and complications of COVID-19: a contemporary review. J Investig Med 2020;68:1334-40. [PMID: 33077488 DOI: 10.1136/jim-2020-001592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
204 Gladka MM, Maack C. The endothelium as Achilles' heel in COVID-19 patients. Cardiovasc Res 2020;116:e195-7. [PMID: 33167001 DOI: 10.1093/cvr/cvaa327] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
205 Vuorio A, Kovanen PT, Raal F. Opportunities for preventing further endothelial dysfunction in pregnant COVID-19 patients with familial hypercholesterolemia. Journal of Clinical Lipidology 2022. [DOI: 10.1016/j.jacl.2022.02.002] [Reference Citation Analysis]
206 Beltrán-García J, Osca-Verdegal R, Pallardó FV, Ferreres J, Rodríguez M, Mulet S, Sanchis-Gomar F, Carbonell N, García-Giménez JL. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.Antioxidants (Basel). 2020;9:936. [PMID: 33003552 DOI: 10.3390/antiox9100936] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
207 Muskiet FAJ, Carrera-bastos P, Pruimboom L, Lucia A, Furman D. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. Nutrients 2022;14:1388. [DOI: 10.3390/nu14071388] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
208 Raman B, Bluemke DA, Lüscher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J 2022:ehac031. [PMID: 35176758 DOI: 10.1093/eurheartj/ehac031] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 19.0] [Reference Citation Analysis]
209 Mester A, Benedek I, Rat N, Tolescu C, Polexa SA, Benedek T. Imaging Cardiovascular Inflammation in the COVID-19 Era. Diagnostics (Basel) 2021;11:1114. [PMID: 34207266 DOI: 10.3390/diagnostics11061114] [Reference Citation Analysis]
210 Mir T, Attique HB, Sattar Y, Regmi N, Khan MS, Youns H, Qayoom B, Jerger MT, Alraies MC. Does pulmonary embolism in critically ill COVID-19 patients worsen the in-hospital mortality: A meta-analysis. Cardiovasc Revasc Med 2020:S1553-8389(20)30780-6. [PMID: 33257254 DOI: 10.1016/j.carrev.2020.11.024] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
211 Ryabkova VA, Churilov LP, Shoenfeld Y. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned. Clin Immunol. 2021;223:108652. [PMID: 33333256 DOI: 10.1016/j.clim.2020.108652] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
212 Matarese A, Gambardella J, Sardu C, Santulli G. miR-98 Regulates TMPRSS2 Expression in Human Endothelial Cells: Key Implications for COVID-19. Biomedicines 2020;8:E462. [PMID: 33143053 DOI: 10.3390/biomedicines8110462] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
213 Aeschlimann FA, Misra N, Hussein T, Panaioli E, Soslow JH, Crum K, Steele JM, Huber S, Marcora S, Brambilla P, Jain S, Navallas M, Giuli V, Rücker B, Angst F, Patel MD, Azarine A, Caro-Domínguez P, Cavaliere A, Di Salvo G, Ferroni F, Agnoletti G, Bonnemains L, Martins D, Boddaert N, Wong J, Pushparajah K, Raimondi F. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study-the CARDOVID registry. J Cardiovasc Magn Reson 2021;23:140. [PMID: 34969397 DOI: 10.1186/s12968-021-00841-1] [Reference Citation Analysis]
214 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells. Noncoding RNA 2021;7:9. [PMID: 33540664 DOI: 10.3390/ncrna7010009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
215 Baltrūnas T, Račytė A, Pikturnaitė G, Skrebūnas A, Vaišnytė B. Aortic thrombosis after DVT and PE in a young COVID-19 patient. Ann Vasc Surg 2021:S0890-5096(21)00498-2. [PMID: 34411673 DOI: 10.1016/j.avsg.2021.07.005] [Reference Citation Analysis]
216 Bikdeli B. Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence. Thromb Res 2020;196:638-40. [PMID: 33066998 DOI: 10.1016/j.thromres.2020.09.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
217 Sansone A, Mollaioli D, Ciocca G, Colonnello E, Limoncin E, Balercia G, Jannini EA. "Mask up to keep it up": Preliminary evidence of the association between erectile dysfunction and COVID-19. Andrology 2021;9:1053-9. [PMID: 33742540 DOI: 10.1111/andr.13003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
218 Ceban F, Ling S, Lui LMW, Lee Y, Gill H, Teopiz KM, Rodrigues NB, Subramaniapillai M, Di Vincenzo JD, Cao B, Lin K, Mansur RB, Ho RC, Rosenblat JD, Miskowiak KW, Vinberg M, Maletic V, McIntyre RS. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun 2022;101:93-135. [PMID: 34973396 DOI: 10.1016/j.bbi.2021.12.020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 29] [Article Influence: 53.0] [Reference Citation Analysis]
219 Nalbandian A, Sehgal K, Gupta A, Madhavan MV, Mcgroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-nigoghossian C, Liyanage-don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med 2021;27:601-15. [DOI: 10.1038/s41591-021-01283-z] [Cited by in Crossref: 209] [Cited by in F6Publishing: 238] [Article Influence: 209.0] [Reference Citation Analysis]
220 Kelham M, Choudry FA, Hamshere S, Beirne AM, Rathod KS, Baumbach A, Ahluwalia A, Mathur A, Jones DA. Therapeutic Implications of COVID-19 for the Interventional Cardiologist. J Cardiovasc Pharmacol Ther 2021;26:203-16. [PMID: 33331160 DOI: 10.1177/1074248420982736] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
221 Deng H, Tang TX, Chen D, Tang LS, Yang XP, Tang ZH. Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies. Pathogens 2021;10:582. [PMID: 34064553 DOI: 10.3390/pathogens10050582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
222 Luo Y, Luo L, Li W, Chen Y, Wu G, Chen F, Shen H, Li H, Guo M, Yin S, Zhang K, Cheng Z. Evaluation of a Functional Single Nucleotide Polymorphism of the SARS-CoV-2 Receptor ACE2 That Is Potentially Involved in Long COVID. Front Genet 2022;13:931562. [DOI: 10.3389/fgene.2022.931562] [Reference Citation Analysis]
223 Mancusi C, Grassi G, Borghi C, Ferri C, Muiesan ML, Volpe M, Iaccarino G; SARS-RAS Investigator Group. Clinical Characteristics and Outcomes of Patients with COVID-19 Infection: The Results of the SARS-RAS Study of the Italian Society of Hypertension. High Blood Press Cardiovasc Prev 2021;28:5-11. [PMID: 33471297 DOI: 10.1007/s40292-020-00429-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
224 Rotoli BM, Barilli A, Visigalli R, Ferrari F, Dall'Asta V. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells. Biomedicines 2021;9:1220. [PMID: 34572407 DOI: 10.3390/biomedicines9091220] [Reference Citation Analysis]
225 Philippe A, Chocron R, Gendron N, Bory O, Beauvais A, Peron N, Khider L, Guerin CL, Goudot G, Levasseur F, Peronino C, Duchemin J, Brichet J, Sourdeau E, Desvard F, Bertil S, Pene F, Cheurfa C, Szwebel TA, Planquette B, Rivet N, Jourdi G, Hauw-Berlemont C, Hermann B, Gaussem P, Mirault T, Terrier B, Sanchez O, Diehl JL, Fontenay M, Smadja DM. Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality. Angiogenesis 2021;24:505-17. [PMID: 33449299 DOI: 10.1007/s10456-020-09762-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
226 Sharma M, Surani S. Revisiting One of the Dreaded Outcomes of the Current Pandemic: Pulmonary Embolism in COVID-19. Medicina (Kaunas) 2020;56:E670. [PMID: 33287199 DOI: 10.3390/medicina56120670] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
227 McCarthy CG, Wilczynski S, Wenceslau CF, Webb RC. A new storm on the horizon in COVID-19: Bradykinin-induced vascular complications. Vascul Pharmacol 2021;137:106826. [PMID: 33358968 DOI: 10.1016/j.vph.2020.106826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
228 Szarpak L, Mierzejewska M, Jurek J, Kochanowska A, Gasecka A, Truszewski Z, Pruc M, Blek N, Rafique Z, Filipiak KJ, Denegri A, Jaguszewski MJ. Effect of Coronary Artery Disease on COVID-19-Prognosis and Risk Assessment: A Systematic Review and Meta-Analysis. Biology (Basel) 2022;11:221. [PMID: 35205088 DOI: 10.3390/biology11020221] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
229 Wautier JL, Wautier MP. Endothelial Cell Participation in Inflammatory Reaction. Int J Mol Sci 2021;22:6341. [PMID: 34199319 DOI: 10.3390/ijms22126341] [Reference Citation Analysis]
230 Moonis G, Filippi CG, Kirsch CFE, Mohan S, Stein EG, Hirsch JA, Mahajan A. The Spectrum of Neuroimaging Findings on CT and MRI in Adults With COVID-19. American Journal of Roentgenology 2021;217:959-74. [DOI: 10.2214/ajr.20.24839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
231 Nuñez-Borque E, Fernandez-Bravo S, Yuste-Montalvo A, Esteban V. Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis. Front Immunol 2022;13:836222. [PMID: 35371072 DOI: 10.3389/fimmu.2022.836222] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
232 Robles JP, Zamora M, Adan-Castro E, Siqueiros-Marquez L, Martinez de la Escalera G, Clapp C. The spike protein of SARS-CoV-2 induces endothelial inflammation through integrin α5β1 and NF-κB signaling. J Biol Chem 2022;:101695. [PMID: 35143839 DOI: 10.1016/j.jbc.2022.101695] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
233 Lu-Culligan A, Chavan AR, Vijayakumar P, Irshaid L, Courchaine EM, Milano KM, Tang Z, Pope SD, Song E, Vogels CBF, Lu-Culligan WJ, Campbell KH, Casanovas-Massana A, Bermejo S, Toothaker JM, Lee HJ, Liu F, Schulz W, Fournier J, Muenker MC, Moore AJ, Konnikova L, Neugebauer KM, Ring A, Grubaugh ND, Ko AI, Morotti R, Guller S, Kliman HJ, Iwasaki A, Farhadian SF; Yale IMPACT Team. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y) 2021;2:591-610.e10. [PMID: 33969332 DOI: 10.1016/j.medj.2021.04.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
234 da Silveira WC, Ramos LEF, Silva RT, de Paiva BBM, Pereira PD, Schwarzbold AV, Garbini AF, Barreira BSM, de Castro BM, Ramos CM, Gomes CD, Cimini CCR, Pereira EC, Roesch EW, Kroger EMS, Aranha FFMG, Anschau F, Botoni FA, Aranha FG, Crestani GP, Vietta GG, Bastos GAN, Costa JHSM, da Fonseca JRCS, Ruschel KB, de Oliveira LS, Pinheiro LS, Pacheco LS, Segala LB, Couto LSF, Kopittke L, Floriani MA, Silva MM, Carneiro M, Ferreira MAP, Martins MAP, de Faria MNZ, Nogueira MCA, Guimarães Júnior MH, Sampaio NDCS, de Oliveira NR, Pertile NM, Andrade PGS, Assaf PL, Valacio RA, Menezes RM, Francisco SC, Guimarães SMM, Araújo SF, Rezende SM, Pereira SA, Kurtz T, Fereguetti TO, Polanczyk CA, Pires MC, Gonçalves MA, Marcolino MS. Predictors of venous thromboembolism in COVID-19 patients: results of the COVID-19 Brazilian Registry. Intern Emerg Med 2022. [PMID: 35648280 DOI: 10.1007/s11739-022-03002-z] [Reference Citation Analysis]
235 Monserrat J, Asunsolo A, Gómez-Lahoz A, Ortega MA, Gasalla JM, Gasulla Ó, Fortuny-Profitós J, Mazaira-Font FA, Teixidó Román M, Arranz A, Sanz J, Muñoz B, Arévalo-Serrano J, Rodríguez JM, Martínez-A C, Balomenos D, Álvarez-Mon M. Impact of the Innate Inflammatory Response on ICU Admission and Death in Hospitalized Patients with COVID-19. Biomedicines 2021;9:1675. [PMID: 34829906 DOI: 10.3390/biomedicines9111675] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Mizera L, Borst O. COVID-19 and the Incidence of Acute Myocardial Injury. Hamostaseologie 2021;41:356-64. [PMID: 34695852 DOI: 10.1055/a-1554-6416] [Reference Citation Analysis]
237 Engin AB, Engin ED, Engin A. Can Iron, Zinc, Copper and Selenium status be a prognostic determinant in COVID-19 patients? Environ Toxicol Pharmacol 2022;:103937. [PMID: 35882309 DOI: 10.1016/j.etap.2022.103937] [Reference Citation Analysis]
238 Terrones-Peinador M, Eremiev-Eremiev S, Pigrau-Serrallach C, Solans-Laque R. Recurrent thrombosis as a clinical presentation of Whipple disease. BMJ Case Rep 2022;15:e247020. [PMID: 35144962 DOI: 10.1136/bcr-2021-247020] [Reference Citation Analysis]
239 Xiang D, Ren X, Chen Q, Yu H, Li X, Liu D. Association of ACEI/ARB, inflammatory cytokines, and antiviral drugs with liver dysfunction in patients with hypertension and COVID-19. Clin Exp Hypertens 2021;43:305-10. [PMID: 33356606 DOI: 10.1080/10641963.2020.1867160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
240 Catar R, Moll G, Hosp I, Simon M, Luecht C, Zhao H, Wu D, Chen L, Kamhieh-Milz J, Korybalska K, Zickler D, Witowski J. Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response. Cells 2021;10:910. [PMID: 33920990 DOI: 10.3390/cells10040910] [Reference Citation Analysis]
241 Tong M, Zheng Q, Chen F, Zhu Y. Reply to Padhi et al. J Infect Dis 2021:jiab280. [PMID: 34192328 DOI: 10.1093/infdis/jiab280] [Reference Citation Analysis]
242 Trimaille A, Bonnet G. [COVID-19 and venous thromboembolism]. Ann Cardiol Angeiol (Paris) 2020;69:370-5. [PMID: 33081917 DOI: 10.1016/j.ancard.2020.09.027] [Reference Citation Analysis]
243 Páramo JA. [Microvascular thrombosis and clinical implications]. Med Clin (Barc) 2021;156:609-14. [PMID: 33875227 DOI: 10.1016/j.medcli.2020.12.042] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
244 Brunetta E, Folci M, Bottazzi B, De Santis M, Gritti G, Protti A, Mapelli SN, Bonovas S, Piovani D, Leone R, My I, Zanon V, Spata G, Bacci M, Supino D, Carnevale S, Sironi M, Davoudian S, Peano C, Landi F, Di Marco F, Raimondi F, Gianatti A, Angelini C, Rambaldi A, Garlanda C, Ciccarelli M, Cecconi M, Mantovani A. Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19. Nat Immunol 2021;22:19-24. [PMID: 33208929 DOI: 10.1038/s41590-020-00832-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 24] [Article Influence: 8.5] [Reference Citation Analysis]
245 Gustafson D, Ngai M, Wu R, Hou H, Schoffel AC, Erice C, Mandla S, Billia F, Wilson MD, Radisic M, Fan E, Trahtemberg U, Baker A, McIntosh C, Fan CS, Dos Santos CC, Kain KC, Hanneman K, Thavendiranathan P, Fish JE, Howe KL. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies. EBioMedicine 2022;78:103982. [PMID: 35405523 DOI: 10.1016/j.ebiom.2022.103982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
246 Mesquida J, Caballer A, Cortese L, Vila C, Karadeniz U, Pagliazzi M, Zanoletti M, Pacheco AP, Castro P, García-de-Acilu M, Mesquita RC, Busch DR, Durduran T; HEMOCOVID-19 Consortium. Peripheral microcirculatory alterations are associated with the severity of acute respiratory distress syndrome in COVID-19 patients admitted to intermediate respiratory and intensive care units. Crit Care 2021;25:381. [PMID: 34749792 DOI: 10.1186/s13054-021-03803-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
247 Saad HM, GamalEl Din SF, Elbokl OM, Adel A. Predictive factors of erectile dysfunction in Egyptian individuals after contracting COVID-19: A prospective case-control study. Andrologia 2021;:e14308. [PMID: 34773422 DOI: 10.1111/and.14308] [Reference Citation Analysis]
248 Pesce M, Agostoni P, Bøtker HE, Brundel B, Davidson SM, De Caterina R, Ferdinandy P, Girao H, Gyöngyösi M, Hulot JS, Lecour S, Perrino C, Schulz R, Sluijter JPG, Steffens S, Tancevski I, Gollmann-Tepeköylü C, Tschöpe C, van Linthout S, Madonna R. COVID-19 related cardiac complications - from clinical evidences to basic mechanisms. Opinion paper of the ESC Working Group on Cellular Biology of the Heart. Cardiovasc Res 2021:cvab201. [PMID: 34117887 DOI: 10.1093/cvr/cvab201] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
249 Bösmüller H, Matter M, Fend F, Tzankov A. The pulmonary pathology of COVID-19. Virchows Arch 2021;478:137-50. [PMID: 33604758 DOI: 10.1007/s00428-021-03053-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
250 Ravid JD, Leiva O, Chitalia VC. Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations. Cells 2022;11:306. [DOI: 10.3390/cells11020306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
251 Heubel AD, Viana AA, Linares SN, do Amaral VT, Schafauser NS, de Oliveira GYO, Ramírez PC, Martinelli B, da Silva Alexandre T, Borghi-Silva A, Ciolac EG, Mendes RG. Determinants of endothelial dysfunction in noncritically ill hospitalized COVID-19 patients: A cross-sectional study. Obesity (Silver Spring) 2021. [PMID: 34554646 DOI: 10.1002/oby.23311] [Reference Citation Analysis]
252 Wijeratne T, Gillard Crewther S, Sales C, Karimi L. COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception-A Systematic Review. Front Neurol 2020;11:607221. [PMID: 33584506 DOI: 10.3389/fneur.2020.607221] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
253 Barrett TJ, Cornwell M, Myndzar K, Rolling CC, Xia Y, Drenkova K, Biebuyck A, Fields AT, Tawil M, Luttrell-Williams E, Yuriditsky E, Smith G, Cotzia P, Neal MD, Kornblith LZ, Pittaluga S, Rapkiewicz AV, Burgess HM, Mohr I, Stapleford KA, Voora D, Ruggles K, Hochman J, Berger JS. Platelets amplify endotheliopathy in COVID-19. Sci Adv 2021;7:eabh2434. [PMID: 34516880 DOI: 10.1126/sciadv.abh2434] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Fels B, Acharya S, Vahldieck C, Graf T, Käding N, Rupp J, Kusche-Vihrog K. Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage. Pflugers Arch 2022. [PMID: 35867189 DOI: 10.1007/s00424-022-02726-3] [Reference Citation Analysis]
255 Ercegovac M, Asanin M, Savic-radojevic A, Ranin J, Matic M, Djukic T, Coric V, Jerotic D, Todorovic N, Milosevic I, Stevanovic G, Simic T, Bukumiric Z, Pljesa-ercegovac M. Antioxidant Genetic Profile Modifies Probability of Developing Neurological Sequelae in Long-COVID. Antioxidants 2022;11:954. [DOI: 10.3390/antiox11050954] [Reference Citation Analysis]
256 Wolf A, Khimani F, Yoon B, Gerhart C, Endsley D, Ray A, Yango A, Flynn S, H.y. Lip G, Gonzalez S, Sathyamoorthy M. The mechanistic basis linking cytokine storm to thrombosis in COVID-19. Thrombosis Update 2022. [DOI: 10.1016/j.tru.2022.100110] [Reference Citation Analysis]
257 Trilling M. What the HEC happens around the heart during COVID-19? Basic Res Cardiol 2021;116:43. [PMID: 34223971 DOI: 10.1007/s00395-021-00883-7] [Reference Citation Analysis]
258 García de Guadiana-Romualdo L, Martínez Martínez M, Rodríguez Mulero MD, Esteban-Torrella P, Hernández Olivo M, Alcaraz García MJ, Campos-Rodríguez V, Sancho-Rodríguez N, Galindo Martínez M, Alcaraz A, Ros Braquehais MS, Báguena Perez-Crespo C, Ramos Arenas V, Tomás Jiménez C, Consuegra-Sánchez L, Conesa-Hernandez A, Piñera-Salmerón P, Bernal-Morell E. Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients. Int J Infect Dis 2021;111:211-8. [PMID: 34461254 DOI: 10.1016/j.ijid.2021.08.058] [Reference Citation Analysis]
259 Pezel T, Garot P, Hovasse T, Unterseeh T, Champagne S, Toupin S, Sanguineti F, Lima JAC, Garot J. Prognostic value of pre-hospitalization stress perfusion cardiovascular magnetic resonance to predict death in patients hospitalized for COVID-19. Arch Cardiovasc Dis 2021;114:781-92. [PMID: 34802962 DOI: 10.1016/j.acvd.2021.10.004] [Reference Citation Analysis]
260 Brem FL, Abu-Al-Tayef T, Rasras H, Mir ZE, Mahi OE, Ouafi NE. Concomitant acute limb ischemia and multiple acute ischemic strokes complicating COVID-19: a case report. Pan Afr Med J 2021;38:275. [PMID: 34122702 DOI: 10.11604/pamj.2021.38.275.28712] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
261 Hermel M, Sweeney M, Ni YM, Bonakdar R, Triffon D, Suhar C, Mehta S, Dalhoumi S, Gray J. Natural Supplements for COVID19-Background, Rationale, and Clinical Trials. J Evid Based Integr Med 2021;26:2515690X211036875. [PMID: 34384258 DOI: 10.1177/2515690X211036875] [Reference Citation Analysis]
262 Antoniades C, Asselbergs FW, Vardas P. The year in cardiovascular medicine 2020: digital health and innovation. Eur Heart J 2021;42:732-9. [PMID: 33388767 DOI: 10.1093/eurheartj/ehaa1065] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
263 de Oliveira AA, Nunes KP. Crosstalk of TLR4, vascular NADPH oxidase, and COVID-19 in diabetes: What are the potential implications? Vascul Pharmacol 2021;139:106879. [PMID: 34051372 DOI: 10.1016/j.vph.2021.106879] [Reference Citation Analysis]
264 Sollini M, Ciccarelli M, Cecconi M, Aghemo A, Morelli P, Gelardi F, Chiti A. Vasculitis changes in COVID-19 survivors with persistent symptoms: an [18F]FDG-PET/CT study. Eur J Nucl Med Mol Imaging 2021;48:1460-6. [PMID: 33123760 DOI: 10.1007/s00259-020-05084-3] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
265 Daniels LB, Ren J, Kumar K, Bui QM, Zhang J, Zhang X, Sawan MA, Eisen H, Longhurst CA, Messer K. Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry. PLoS One 2021;16:e0254635. [PMID: 34264974 DOI: 10.1371/journal.pone.0254635] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
266 Babkina AS, Ostrova IV, Yadgarov MY, Kuzovlev AN, Grechko AV, Volkov AV, Golubev AM. The Role of Von Willebrand Factor in the Pathogenesis of Pulmonary Vascular Thrombosis in COVID-19. Viruses 2022;14:211. [DOI: 10.3390/v14020211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
267 Riotto E, Mégevand V, Mégevand A, Marti C, Pugin J, Stangos AN, Marconi Archinto L, Sunaric Mégevand G. Retinal Manifestations in Patients with COVID-19: A Prospective Cohort Study. J Clin Med 2022;11:1828. [PMID: 35407441 DOI: 10.3390/jcm11071828] [Reference Citation Analysis]
268 Brzezinski RY, Rabin N, Lewis N, Peled R, Kerpel A, Tsur AM, Gendelman O, Naftali-Shani N, Gringauz I, Amital H, Leibowitz A, Mayan H, Ben-Zvi I, Heller E, Shechtman L, Rogowski O, Shenhar-Tsarfaty S, Konen E, Marom EM, Ironi A, Rahav G, Zimmer Y, Grossman E, Ovadia-Blechman Z, Leor J, Hoffer O. Automated processing of thermal imaging to detect COVID-19. Sci Rep 2021;11:17489. [PMID: 34471180 DOI: 10.1038/s41598-021-96900-9] [Reference Citation Analysis]
269 Sadeghipour P, Talasaz AH, Rashidi F, Sharif-Kashani B, Beigmohammadi MT, Farrokhpour M, Sezavar SH, Payandemehr P, Dabbagh A, Moghadam KG, Jamalkhani S, Khalili H, Yadollahzadeh M, Riahi T, Rezaeifar P, Tahamtan O, Matin S, Abedini A, Lookzadeh S, Rahmani H, Zoghi E, Mohammadi K, Sadeghipour P, Abri H, Tabrizi S, Mousavian SM, Shahmirzaei S, Bakhshandeh H, Amin A, Rafiee F, Baghizadeh E, Mohebbi B, Parhizgar SE, Aliannejad R, Eslami V, Kashefizadeh A, Kakavand H, Hosseini SH, Shafaghi S, Ghazi SF, Najafi A, Jimenez D, Gupta A, Madhavan MV, Sethi SS, Parikh SA, Monreal M, Hadavand N, Hajighasemi A, Maleki M, Sadeghian S, Piazza G, Kirtane AJ, Van Tassell BW, Dobesh PP, Stone GW, Lip GYH, Krumholz HM, Goldhaber SZ, Bikdeli B; INSPIRATION Investigators. Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial. JAMA 2021;325:1620-30. [PMID: 33734299 DOI: 10.1001/jama.2021.4152] [Cited by in Crossref: 244] [Cited by in F6Publishing: 177] [Article Influence: 244.0] [Reference Citation Analysis]
270 Jarrott B, Head R, Pringle KG, Lumbers ER, Martin JH. "LONG COVID"-A hypothesis for understanding the biological basis and pharmacological treatment strategy. Pharmacol Res Perspect 2022;10:e00911. [PMID: 35029046 DOI: 10.1002/prp2.911] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
271 Oba S, Hosoya T, Amamiya M, Mitsumura T, Kawata D, Sasaki H, Kamiya M, Yamamoto A, Ando T, Shimada S, Shirai T, Okamoto T, Tateishi T, Endo A, Aiboshi J, Nosaka N, Yamanouchi H, Ugawa T, Nagaoka E, Oi K, Tao S, Maejima Y, Tanaka Y, Tanimoto K, Takeuchi H, Tohda S, Hirakawa A, Sasano T, Arai H, Otomo Y, Miyazaki Y, Yasuda S. Arterial and Venous Thrombosis Complicated in COVID-19: A Retrospective Single Center Analysis in Japan. Front Cardiovasc Med 2021;8:767074. [PMID: 34869681 DOI: 10.3389/fcvm.2021.767074] [Reference Citation Analysis]
272 Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, Greenhalgh T. Persistent symptoms after Covid-19: qualitative study of 114 "long Covid" patients and draft quality principles for services. BMC Health Serv Res 2020;20:1144. [PMID: 33342437 DOI: 10.1186/s12913-020-06001-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 28.5] [Reference Citation Analysis]
273 Adams JA, Lopez JR, Uryash A, Sackner MA. Whole body periodic acceleration (pGz) improves endotoxin induced cardiomyocyte contractile dysfunction and attenuates the inflammatory response in mice. Heliyon 2021;7:e06444. [PMID: 33748496 DOI: 10.1016/j.heliyon.2021.e06444] [Reference Citation Analysis]
274 Romiti GF, Corica B, Lip GYH, Proietti M. Prevalence and Impact of Atrial Fibrillation in Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:2490. [PMID: 34199857 DOI: 10.3390/jcm10112490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
275 Polimeni A, Leo I, Spaccarotella C, Mongiardo A, Sorrentino S, Sabatino J, De Rosa S, Indolfi C. Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients. Sci Rep 2021;11:10464. [PMID: 34001992 DOI: 10.1038/s41598-021-89967-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
276 Webb C, Davidson B, Jones ESW, Wearne N, Chetty DR, Blom D, Barday Z. COVID-19-Associated Graft Loss From Renal Infarction in a Kidney Transplant Recipient. Kidney Int Rep 2021;6:1166-9. [PMID: 33553853 DOI: 10.1016/j.ekir.2021.01.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
277 Oliynyk O, Barg W, Slifirczyk A, Oliynyk Y, Dubrov S, Gurianov V, Rorat M. Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy. Life (Basel) 2021;11:1032. [PMID: 34685403 DOI: 10.3390/life11101032] [Reference Citation Analysis]
278 Caillon A, Trimaille A, Favre J, Jesel L, Morel O, Kauffenstein G. Role of neutrophils, platelets, and extracellular vesicles and their interactions in COVID-19-associated thrombopathy. J Thromb Haemost 2021. [PMID: 34672094 DOI: 10.1111/jth.15566] [Reference Citation Analysis]
279 Akbarialiabad H, Taghrir MH, Abdollahi A, Ghahramani N, Kumar M, Paydar S, Razani B, Mwangi J, Asadi-Pooya AA, Malekmakan L, Bastani B. Long COVID, a comprehensive systematic scoping review. Infection 2021. [PMID: 34319569 DOI: 10.1007/s15010-021-01666-x] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
280 Matucci-Cerinic M, Hughes M, Taliani G, Kahaleh B. Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma. Autoimmun Rev 2021;20:102899. [PMID: 34274540 DOI: 10.1016/j.autrev.2021.102899] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
281 Jabczyk M, Nowak J, Hudzik B, Zubelewicz-Szkodzińska B. Microbiota and Its Impact on the Immune System in COVID-19-A Narrative Review. J Clin Med 2021;10:4537. [PMID: 34640553 DOI: 10.3390/jcm10194537] [Reference Citation Analysis]
282 Bianconi V, Mannarino MR, Figorilli F, Schiaroli E, Cosentini E, Batori G, Marini E, Sahebkar A, Grignani F, Gidari A, Francisci D, Pirro M. Low Brachial Artery Flow-Mediated Dilation Predicts Worse Prognosis in Hospitalized Patients with COVID-19. J Clin Med 2021;10:5456. [PMID: 34830738 DOI: 10.3390/jcm10225456] [Reference Citation Analysis]
283 Izzo R, Trimarco V, Mone P, Aloè T, Marzani MC, Diana A, Fazio G, Mallardo M, Maniscalco M, Marazzi G, Messina N, Mininni S, Mussi C, Pelaia G, Pennisi A, Santus P, Scarpelli F, Tursi F, Zanforlin A, Santulli G, Trimarco B. Combining L-Arginine with Vitamin C Improves Long-COVID Symptoms: The Nationwide Multicenter LINCOLN Study. Pharmacol Res 2022;:106360. [PMID: 35868478 DOI: 10.1016/j.phrs.2022.106360] [Reference Citation Analysis]
284 Norooznezhad AH, Mansouri K. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19). Microvasc Res 2021;137:104188. [PMID: 34022205 DOI: 10.1016/j.mvr.2021.104188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
285 Robayo-Amortegui H, Valenzuela-Faccini N, Quecano-Rosas C, Zabala-Muñoz D, Perez-Garzon M. Cerebral venous thrombosis in a patient with Down syndrome and coronavirus disease 2019: a case report. J Med Case Rep 2021;15:364. [PMID: 34253238 DOI: 10.1186/s13256-021-02908-0] [Reference Citation Analysis]
286 Mahdi A, Collado A, Tengbom J, Jiao T, Wodaje T, Johansson N, Farnebo F, Färnert A, Yang J, Lundberg JO, Zhou Z, Pernow J. Erythrocytes Induce Vascular Dysfunction in COVID-19. JACC Basic Transl Sci 2022;7:193-204. [PMID: 35194565 DOI: 10.1016/j.jacbts.2021.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
287 Smadja DM, Philippe A, Bory O, Gendron N, Beauvais A, Gruest M, Peron N, Khider L, Guerin CL, Goudot G, Levavasseur F, Duchemin J, Pene F, Cheurfa C, Szwebel TA, Sourdeau E, Planquette B, Hauw-Berlemont C, Hermann B, Gaussem P, Samama CM, Mirault T, Terrier B, Sanchez O, Rance B, Fontenay M, Diehl JL, Chocron R. Placental growth factor level in plasma predicts COVID-19 severity and in-hospital mortality. J Thromb Haemost 2021;19:1823-30. [PMID: 33830623 DOI: 10.1111/jth.15339] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
288 Matli K, Farah R, Maalouf M, Chamoun N, Costanian C, Ghanem G. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021;8:e001628. [PMID: 34099529 DOI: 10.1136/openhrt-2021-001628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
289 Mejia-Renteria H, Travieso A, Sagir A, Martínez-Gómez E, Carrascosa-Granada A, Toya T, Núñez-Gil IJ, Estrada V, Lerman A, Escaned J. In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19. Int J Cardiol 2021;345:153-5. [PMID: 34706286 DOI: 10.1016/j.ijcard.2021.10.140] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
290 Rizza S, Nucera A, Chiocchi M, Bellia A, Mereu D, Ferrazza G, Ballanti M, Davato F, Di Cola G, Buonomo CO, Coppeta L, Vanni G, Gervasi R, Cardellini M, Lauro D, Federici M. Metabolic characteristics in patients with COVID-19 and no-COVID-19 interstitial pneumonia with mild-to-moderate symptoms and similar radiological severity. Nutr Metab Cardiovasc Dis 2021;31:3227-35. [PMID: 34629249 DOI: 10.1016/j.numecd.2021.08.035] [Reference Citation Analysis]
291 Vuorio A, Raal F, Kovanen PT. Hospitalized Children With Familial Hypercholesterolemia and COVID-19: A Case for Preventive Anticoagulation. Front Cardiovasc Med 2021;8:657719. [PMID: 33959645 DOI: 10.3389/fcvm.2021.657719] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
292 Bai Y, Liang Y, Wang F, Chen L, Zhao Y, Zhao S, Zhu Y, Dong Y, Liang G, Chen D, Liu L. Clinical course and outcomes of COVID-19 patients with a history of cerebrovascular disease: a retrospective study in Wuhan. Ann Transl Med 2021;9:988. [PMID: 34277788 DOI: 10.21037/atm-21-2237] [Reference Citation Analysis]
293 Seelhammer TG, Plack D, Lal A, Nabzdyk CGS. COVID-19 and ECMO: An Unhappy Marriage of Endothelial Dysfunction and Hemostatic Derangements. J Cardiothorac Vasc Anesth 2020;34:3193-6. [PMID: 33228917 DOI: 10.1053/j.jvca.2020.09.132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
294 Talasaz AH, Sadeghipour P, Aghakouchakzadeh M, Kakavand H, Ariannejad H, Connors JM, Hunt BJ, Berger JS, Van Tassell BW, Middeldorp S, Piazza G, Weitz JI, Cushman M, Lip GYH, Goldhaber SZ, Bikdeli B. Use of novel antithrombotic agents for COVID-19: Systematic summary of ongoing randomized controlled trials. J Thromb Haemost 2021. [PMID: 34538017 DOI: 10.1111/jth.15533] [Reference Citation Analysis]
295 Kincaid KJ, Simpkins AN. Failure of Anticoagulation to Prevent Stroke in Context of Lupus-Associated Anti-Phospholipid Syndrome and Mild COVID-19. J Stroke Cerebrovasc Dis 2021;30:105817. [PMID: 33933349 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105817] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
296 Whitmore HAB, Kim LA. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19). Am J Pathol 2021:S0002-9440(21)00260-1. [PMID: 34126084 DOI: 10.1016/j.ajpath.2021.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
297 Rauti R, Shahoha M, Leichtmann-Bardoogo Y, Nasser R, Paz E, Tamir R, Miller V, Babich T, Shaked K, Ehrlich A, Ioannidis K, Nahmias Y, Sharan R, Ashery U, Maoz BM. Effect of SARS-CoV-2 proteins on vascular permeability. Elife 2021;10:e69314. [PMID: 34694226 DOI: 10.7554/eLife.69314] [Reference Citation Analysis]
298 Danchin N, Marijon E. COVID-19 pandemic: preventing hospital myocardial infarction admissions or preventing acute myocardial infarction altogether? Heart 2021:heartjnl-2020-318646. [PMID: 33526507 DOI: 10.1136/heartjnl-2020-318646] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Kite TA, Pallikadavath S, Gale CP, Curzen N, Ladwiniec A. The Direct and Indirect Effects of COVID-19 on Acute Coronary Syndromes. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.03.002] [Reference Citation Analysis]
300 Biasco L, Valotta A, Klersy C, Valgimigli M, Gabutti L, Bruna RD, Pagnamenta A, Ruinelli L, Senatore G, Pedrazzini GB. Association among myocardial injury and mortality in Influenza: A prospective cohort study. International Journal of Cardiology 2022. [DOI: 10.1016/j.ijcard.2022.08.016] [Reference Citation Analysis]
301 Wei G, Gu J, Gu Z, Du C, Huang X, Xing H, Li L, Zhang A, Hu X, Huo J. Olfactory Dysfunction in Patients With Coronavirus Disease 2019: A Review. Front Neurol 2022;12:783249. [DOI: 10.3389/fneur.2021.783249] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
302 Andrade SAD, de Souza DA, Torres AL, de Lima CFG, Ebram MC, Celano RMG, Schattner M, Chudzinski-tavassi AM. Pathophysiology of COVID-19: Critical Role of Hemostasis. Front Cell Infect Microbiol 2022;12:896972. [DOI: 10.3389/fcimb.2022.896972] [Reference Citation Analysis]
303 Berrichi S, Bouayed Z, Berrajaa S, Mezzeoui SE, Moujahid A, Nasri S, Bkiyar H, Skiker I, Housni B. Acute limb ischemia with concomitant splenic and renal infarcts: Thromboembolic events revealing COVID-19. Ann Med Surg (Lond) 2021;68:102646. [PMID: 34341687 DOI: 10.1016/j.amsu.2021.102646] [Reference Citation Analysis]
304 Vuorio A, Raal F, Klingel R, Kovanen PT. Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19. J Clin Lipidol 2021;15:379-80. [PMID: 34099192 DOI: 10.1016/j.jacl.2021.02.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
305 Zahreddine R, Davezac M, Buscato M, Smirnova N, Laffargue M, Henrion D, Adlanmerini M, Lenfant F, Arnal JF, Fontaine C. A historical view of estrogen effect on arterial endothelial healing: From animal models to medical implication. Atherosclerosis 2021;338:30-8. [PMID: 34785429 DOI: 10.1016/j.atherosclerosis.2021.10.013] [Reference Citation Analysis]
306 Gawaz A, Guenova E. Microvascular Skin Manifestations Caused by COVID-19. Hamostaseologie 2021;41:387-96. [PMID: 34695855 DOI: 10.1055/a-1581-6899] [Reference Citation Analysis]
307 Anipindi M, Scott A, Joyce L, Wali S, Morginstin M. Case Report: Cerebral Venous Sinus Thrombosis and COVID-19 Infection. Front Med (Lausanne) 2021;8:741594. [PMID: 34722579 DOI: 10.3389/fmed.2021.741594] [Reference Citation Analysis]
308 Rayner C, Campbell R. Long Covid Implications for the workplace. Occup Med (Lond) 2021;71:121-3. [PMID: 33822179 DOI: 10.1093/occmed/kqab042] [Reference Citation Analysis]
309 Jamil A, Shyam V, Neupane K. Atypical Presentation of Pulmonary Embolism Several Months After COVID-19 Infection. Cureus 2021;13:e12863. [PMID: 33633893 DOI: 10.7759/cureus.12863] [Reference Citation Analysis]
310 Daniels LB, Kumar K. The role of statin therapy in COVID-19. Expert Rev Cardiovasc Ther 2022. [PMID: 35608055 DOI: 10.1080/14779072.2022.2081548] [Reference Citation Analysis]
311 Bunch CM, Moore EE, Moore HB, Neal MD, Thomas AV, Zackariya N, Zhao J, Zackariya S, Brenner TJ, Berquist M, Buckner H, Wiarda G, Fulkerson D, Huff W, Kwaan HC, Lankowicz G, Laubscher GJ, Lourens PJ, Pretorius E, Kotze MJ, Moolla MS, Sithole S, Maponga TG, Kell DB, Fox MD, Gillespie L, Khan RZ, Mamczak CN, March R, Macias R, Bull BS, Walsh MM. Immuno-Thrombotic Complications of COVID-19: Implications for Timing of Surgery and Anticoagulation. Front Surg 2022;9:889999. [DOI: 10.3389/fsurg.2022.889999] [Reference Citation Analysis]
312 Miyara SJ, Becker LB, Guevara S, Kirsch C, Metz CN, Shoaib M, Grodstein E, Nair VV, Jandovitz N, McCann-Molmenti A, Hayashida K, Takegawa R, Shinozaki K, Yagi T, Aoki T, Nishikimi M, Choudhary RC, Cho YM, Zanos S, Zafeiropoulos S, Hoffman HB, Watt S, Lumermann CM, Aronsohn J, Shore-Lesserson L, Molmenti EP. Pneumatosis Intestinalis in the Setting of COVID-19: A Single Center Case Series From New York. Front Med (Lausanne) 2021;8:638075. [PMID: 34150792 DOI: 10.3389/fmed.2021.638075] [Reference Citation Analysis]
313 Palmos AB, Millischer V, Menon DK, Nicholson TR, Taams LS, Michael B, Sunderland G, Griffiths MJ, Hübel C, Breen G; COVID Clinical Neuroscience Study Consortium. Proteome-wide Mendelian randomization identifies causal links between blood proteins and severe COVID-19. PLoS Genet 2022;18:e1010042. [PMID: 35239653 DOI: 10.1371/journal.pgen.1010042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
314 Erdoğan M, Öztürk S, Erdöl MA, Kasapkara A, Beşler MS, Kayaaslan B, Hasanoğlu İ, Durmaz T, Güner R. Prognostic utility of pulmonary artery and ascending aorta diameters derived from computed tomography in COVID-19 patients. Echocardiography 2021. [PMID: 34355824 DOI: 10.1111/echo.15170] [Reference Citation Analysis]
315 Ball L, Silva PL, Giacobbe DR, Bassetti M, Zubieta-Calleja GR, Rocco PRM, Pelosi P. Understanding the pathophysiology of typical acute respiratory distress syndrome and severe COVID-19. Expert Rev Respir Med 2022. [PMID: 35341424 DOI: 10.1080/17476348.2022.2057300] [Reference Citation Analysis]
316 Fouani Y, Kirchhof L, Stanicek L, Luxán G, Heumüller AW, Knau A, Fischer A, Devraj K, John D, Neumann P, Bindereif A, Boon RA, Liebner S, Wittig I, Mogler C, Karimova M, Dimmeler S, Jaé N. The splicing-regulatory lncRNA NTRAS sustains vascular integrity. EMBO Rep 2022;23:e54157. [PMID: 35527520 DOI: 10.15252/embr.202154157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
317 Hu Z, Cano I, D'Amore PA. Update on the Role of the Endothelial Glycocalyx in Angiogenesis and Vascular Inflammation. Front Cell Dev Biol 2021;9:734276. [PMID: 34532323 DOI: 10.3389/fcell.2021.734276] [Reference Citation Analysis]
318 Ceci Bonello E, Casha R, Xerri T, Bonello J, Fsadni C, Mallia Azzopardi C. Multiorgan thrombosis as a complication of COVID-19 pneumonia. BMJ Case Rep 2021;14:e243953. [PMID: 34321271 DOI: 10.1136/bcr-2021-243953] [Reference Citation Analysis]
319 Ackermann M, Anders HJ, Bilyy R, Bowlin GL, Daniel C, De Lorenzo R, Egeblad M, Henneck T, Hidalgo A, Hoffmann M, Hohberger B, Kanthi Y, Kaplan MJ, Knight JS, Knopf J, Kolaczkowska E, Kubes P, Leppkes M, Mahajan A, Manfredi AA, Maueröder C, Maugeri N, Mitroulis I, Muñoz LE, Narasaraju T, Naschberger E, Neeli I, Ng LG, Radic MZ, Ritis K, Rovere-Querini P, Schapher M, Schauer C, Simon HU, Singh J, Skendros P, Stark K, Stürzl M, van der Vlag J, Vandenabeele P, Vitkov L, von Köckritz-Blickwede M, Yanginlar C, Yousefi S, Zarbock A, Schett G, Herrmann M. Patients with COVID-19: in the dark-NETs of neutrophils. Cell Death Differ 2021. [PMID: 34031543 DOI: 10.1038/s41418-021-00805-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
320 Lee CCE, Ali K, Connell D, Mordi IR, George J, Lang EM, Lang CC. COVID-19-Associated Cardiovascular Complications. Diseases 2021;9:47. [PMID: 34209705 DOI: 10.3390/diseases9030047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
321 Dholariya S, Parchwani DN, Singh R, Radadiya M, Katoch CDS. Utility of P-SEP, sTREM-1 and suPAR as Novel Sepsis Biomarkers in SARS-CoV-2 Infection. Indian J Clin Biochem 2021;:1-8. [PMID: 34642555 DOI: 10.1007/s12291-021-01008-6] [Reference Citation Analysis]
322 Ding J, Song B, Xie X, Li X, Chen Z, Wang Z, Pan L, Lan D, Meng R. Inflammation in Cerebral Venous Thrombosis. Front Immunol 2022;13:833490. [DOI: 10.3389/fimmu.2022.833490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
323 Boudhabhay I, Rabant M, Roumenina LT, Coupry LM, Poillerat V, Marchal A, Frémeaux-Bacchi V, El Karoui K, Monchi M, Pourcine F. Case Report: Adult Post-COVID-19 Multisystem Inflammatory Syndrome and Thrombotic Microangiopathy. Front Immunol 2021;12:680567. [PMID: 34248962 DOI: 10.3389/fimmu.2021.680567] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
324 Suhartono R, Nugroho NT. Dealing with Hypercoagulability Problem in COVID-19 Cases. JINASVS 2021;2:vi-vii. [DOI: 10.36864/jinasvs.2021.1.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
325 Baylis RA, Smith NL, Klarin D, Fukaya E. Epidemiology and Genetics of Venous Thromboembolism and Chronic Venous Disease. Circ Res 2021;128:1988-2002. [PMID: 34110897 DOI: 10.1161/CIRCRESAHA.121.318322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 Gonzalez I, Lindner C, Schneider I, Morales MA, Rojas A. Inflammation at the crossroads of Helicobacter pylori and COVID-19. Future Microbiol 2022;17:77-80. [PMID: 34915742 DOI: 10.2217/fmb-2021-0250] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
327 Sabater Molina M, Nicolás Rocamora E, Bendicho AI, Vázquez EG, Zorio E, Rodriguez FD, Gil Ortuño C, Rodríguez AI, Sánchez-López AJ, Jara Rubio R, Moreno-Docón A, Marcos PJ, García Pavía P, Villa RB, Gimeno Blanes JR. Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease. PLoS One 2022;17:e0263140. [PMID: 35120165 DOI: 10.1371/journal.pone.0263140] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
328 Moroni F, Baldetti L. COVID-19 and arterial thrombosis: A potentially fatal combination. Int J Cardiol 2021;322:286-90. [PMID: 33091523 DOI: 10.1016/j.ijcard.2020.10.046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
329 Meizoso JP, Moore HB, Moore EE. Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications. J Am Coll Surg 2021;232:995-1003. [PMID: 33766727 DOI: 10.1016/j.jamcollsurg.2021.02.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
330 Cooke JP, Connor JH, Jain A. Acute and Chronic Cardiovascular Manifestations of COVID-19: Role for Endotheliopathy. Methodist Debakey Cardiovasc J 2021;17:53-62. [PMID: 34992723 DOI: 10.14797/mdcvj.1044] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
331 Muschitz C, Trummert A, Berent T, Laimer N, Knoblich L, Bodlaj G, Krainer A, Linder C, Resch H. Attenuation of COVID-19-induced cytokine storm in a young male patient with severe respiratory and neurological symptoms. Wien Klin Wochenschr 2021. [PMID: 33905029 DOI: 10.1007/s00508-021-01867-2] [Reference Citation Analysis]
332 Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. Cardiovascular Health and Disease in the Context of COVID-19. Cardiol Res 2021;12:67-79. [PMID: 33738009 DOI: 10.14740/cr1199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
333 Maruhashi T, Higashi Y. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19. Int J Mol Sci 2021;22:5131. [PMID: 34066226 DOI: 10.3390/ijms22105131] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
334 Li M, Qian M, Kyler K, Xu J. Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial Dysfunction. Front Cardiovasc Med 2021;8:681581. [PMID: 34277732 DOI: 10.3389/fcvm.2021.681581] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
335 Worth H, Helmlinger K, Raj R, Heidel E, Lands R. Thromboembolic Rates Are Similar Between Intensive Care Unit and Nonintensive Care Unit Hospitalized Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Retrospective Cohort Study. Clin Appl Thromb Hemost 2021;27:10760296211053315. [PMID: 34786969 DOI: 10.1177/10760296211053315] [Reference Citation Analysis]
336 [DOI: 10.1101/2020.06.01.20119651] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
337 López García de Lomana A, Vilhjálmsson AI, McGarrity S, Sigurðardóttir R, Anuforo Ó, Viktorsdóttir AR, Kotronoulas A, Bergmann A, Franzson L, Halldórsson H, Henriksen HH, Wade CE, Johansson PI, Rolfsson Ó. Metabolic Response in Endothelial Cells to Catecholamine Stimulation Associated with Increased Vascular Permeability. Int J Mol Sci 2022;23:3162. [PMID: 35328583 DOI: 10.3390/ijms23063162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
338 Raisi-Estabragh Z, McCracken C, Cooper J, Fung K, Paiva JM, Khanji MY, Rauseo E, Biasiolli L, Raman B, Piechnik SK, Neubauer S, Munroe PB, Harvey NC, Petersen SE. Adverse cardiovascular magnetic resonance phenotypes are associated with greater likelihood of incident coronavirus disease 2019: findings from the UK Biobank. Aging Clin Exp Res 2021;33:1133-44. [PMID: 33683678 DOI: 10.1007/s40520-021-01808-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
339 Varshney AS, Wang DE, Bhatt AS, Blood A, Sharkawi MA, Siddiqi HK, Vaduganathan M, Monteleone PP, Patel MR, Jones WS, Lopes RD, Mehra MR, Bhatt DL, Kochar A. Characteristics of clinical trials evaluating cardiovascular therapies for Coronavirus Disease 2019 Registered on ClinicalTrials.gov: a cross sectional analysis. Am Heart J 2021;232:105-15. [PMID: 33121978 DOI: 10.1016/j.ahj.2020.10.065] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
340 Laouan Brem F, Asmae B, Amane Y, Bouazzaoui MA, Chaymae M, Rasras H, Nasri S, Abda N, Skiker I, Kouismi H, Zakaria B, Ismaili N, El Ouafi N. Diagnostic Accuracy of D-Dimers for Predicting Pulmonary Embolism in COVID-19-Patients. Clin Appl Thromb Hemost 2021;27:10760296211057901. [PMID: 34905979 DOI: 10.1177/10760296211057901] [Reference Citation Analysis]
341 [DOI: 10.1101/2020.12.09.20246389] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
342 Popadic V, Klasnja S, Milic N, Rajovic N, Aleksic A, Milenkovic M, Crnokrak B, Balint B, Todorovic-Balint M, Mrda D, Zdravkovic D, Toskovic B, Brankovic M, Markovic O, Bjekic-Macut J, Djuran P, Memon L, Brajkovic M, Todorovic Z, Hadzi-Djokic J, Jovanovic I, Nikolic D, Zdravkovic M. Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy. Oxid Med Cell Longev 2021;2021:6648199. [PMID: 33968298 DOI: 10.1155/2021/6648199] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
343 Hosseinzadeh A, Bagherifard A, Koosha F, Amiri S, Karimi-behnagh A, Reiter RJ, Mehrzadi S. Melatonin effect on platelets and coagulation: Implications for a prophylactic indication in COVID-19. Life Sciences 2022. [DOI: 10.1016/j.lfs.2022.120866] [Reference Citation Analysis]
344 Sweet DR, Lam C, Jain MK. Evolutionary Protection of Krüppel-Like Factors 2 and 4 in the Development of the Mature Hemovascular System. Front Cardiovasc Med 2021;8:645719. [PMID: 34079826 DOI: 10.3389/fcvm.2021.645719] [Reference Citation Analysis]
345 Yang Q, Wijerathne H, Langston JC, Kiani MF, Kilpatrick LE. Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. Int J Mol Sci 2021;22:7770. [PMID: 34360536 DOI: 10.3390/ijms22157770] [Reference Citation Analysis]
346 Çorapli G, Çil E, Şahin Tutak A, Çorapli M. The effect of main pulmonary artery diameter on the prognosis of COVID-19 patients in the ICU. J Health Sci Med / JHSM 2022;5:778-81. [DOI: 10.32322/jhsm.1072443] [Reference Citation Analysis]
347 Ji W, Hu Q, Zhang M, Zhang C, Chen C, Yan Y, Zhang X, Chen S, Tao L, Zhang W, Jin Y, Duan G. The Disruption of the Endothelial Barrier Contributes to Acute Lung Injury Induced by Coxsackievirus A2 Infection in Mice. Int J Mol Sci 2021;22:9895. [PMID: 34576058 DOI: 10.3390/ijms22189895] [Reference Citation Analysis]
348 Steckelings UM, Sumners C. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists. Clin Sci (Lond) 2020;134:2987-3006. [PMID: 33210709 DOI: 10.1042/CS20200922] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
349 Dupont A, Rauch A, Staessens S, Moussa M, Rosa M, Corseaux D, Jeanpierre E, Goutay J, Caplan M, Varlet P, Lefevre G, Lassalle F, Bauters A, Faure K, Lambert M, Duhamel A, Labreuche J, Garrigue D, De Meyer SF, Staels B, Vincent F, Rousse N, Kipnis E, Lenting P, Poissy J, Susen S; Lille Covid Research Network (LICORNE). Vascular Endothelial Damage in the Pathogenesis of Organ Injury in Severe COVID-19. Arterioscler Thromb Vasc Biol 2021;41:1760-73. [PMID: 33626910 DOI: 10.1161/ATVBAHA.120.315595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
350 Nehme R, Fleifel M, Abou Khalil M, Al Dailaty A. A case of massive saddle pulmonary embolism and benign tracheal stenosis in a patient with COVID-19 infection. Respirol Case Rep 2021;9:e0861. [PMID: 34631107 DOI: 10.1002/rcr2.861] [Reference Citation Analysis]
351 Sevim M, Alkis O, Kartal İG, Telli S, Aras B. A factor not to be ignored in post-COVID-19 erectile dysfunction; psychological effect, a prospective study. Andrologia 2022. [PMID: 35445425 DOI: 10.1111/and.14443] [Reference Citation Analysis]